hg_234995.1

Basic information about the TSS

---

TSS ID: hg_234995.1 Species: human Chr: chr14		Start: 102085785 End: 102085792 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000555662.1 Distance: 79 GeneID: 3320 HGNC/MGI_ID: HGNC:5253 UniProt_ID:

Gene_name: heat shock protein 90 alpha family class A member 1 Gene_symbol: HSP90AA1 Gene_synonyms: FLJ31884 HSP90N Hsp89 Hsp90 Gene_source: HGNC:5253

TATA-Box annotation

---

Distance to TSS:	25
Nearest PromoterID:	NM_012090
Entrez ID:	23499
Nearest Unigene:	Hs.472475
Nearest Refseq:	NM_012090
Nearest Ensembl:	ENSG00000127603
Gene Name:	heat shock protein 90 alpha family class A member 1
Gene Alias:	ABP620|ACF7|LIS9|MACF|OFC4
Gene Description:	microtubule actin crosslinking factor 1
Gene Type:	protein-coding
CpG%:	0.035
GC%:	0.587065
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HSP90AA1 p2@HSP90AA1 p3@HSP90AA1 p4@HSP90AA1 p5@HSP90AA1 p6@HSP90AA1 p7@HSP90AA1 p8@HSP90AA1 p9@HSP90AA1 p10@HSP90AA1
Sample		p1@HSP90AA1	p2@HSP90AA1	p3@HSP90AA1	p4@HSP90AA1	p5@HSP90AA1	p6@HSP90AA1	p7@HSP90AA1	p8@HSP90AA1	p9@HSP90AA1	p10@HSP90AA1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	925.51	10.91	33.51	2.53	0.78	2.14	0.97	1.75	5.06	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	941.19	7.89	40.46	3.24	0.20	3.24	1.21	1.42	4.86	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	1126.56	10.61	58.64	2.51	0.19	5.21	2.12	0.77	7.14	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	810.43	6.86	26.82	2.29	0.62	0.62	1.25	0.62	4.99	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	878.72	8.55	32.85	2.47	0.00	1.35	1.12	0.45	4.50	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	902.38	8.92	34.89	5.04	0.78	3.88	1.36	0.97	6.20	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1255.01	15.03	48.81	3.92	0.22	6.32	2.61	1.96	10.24	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1021.92	6.06	32.46	2.42	0.48	2.18	0.97	1.94	7.02	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	982.03	7.91	24.36	2.56	0.64	1.50	1.50	1.71	7.91	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	491.52	3.48	12.75	0.58	0.58	1.16	0.00	0.58	15.07	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	468.51	4.04	11.32	2.02	0.40	0.81	0.81	1.21	10.91	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	497.62	2.85	8.13	2.44	1.63	1.22	0.41	0.41	11.79	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	292.08	5.16	4.84	4.67	2.42	1.77	0.64	1.13	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	338.74	6.16	4.36	4.06	1.65	2.56	1.35	0.90	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	300.79	4.83	6.59	2.85	1.54	1.76	0.66	1.10	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	271.86	2.77	5.53	2.01	0.50	0.25	1.26	0.75	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	283.93	4.59	5.24	2.84	0.87	1.53	0.87	0.44	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	274.18	4.64	9.28	4.22	1.27	2.11	1.27	0.84	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	274.57	4.80	9.06	1.60	2.67	0.53	1.07	0.00	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	259.51	4.81	5.72	3.46	1.50	1.81	0.90	0.30	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	297.11	4.41	2.81	3.21	0.80	1.07	1.34	0.80	1.20	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	301.23	3.45	5.18	4.14	0.86	1.38	0.00	0.69	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	286.18	3.36	4.39	3.88	0.52	0.78	0.52	0.26	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	286.11	3.88	5.34	2.91	0.73	1.21	2.43	2.67	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	306.23	3.35	3.61	2.32	1.29	1.81	0.77	0.26	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	285.18	3.48	7.91	3.17	0.95	3.17	1.27	0.32	0.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	302.20	6.04	9.34	4.95	2.20	0.00	1.65	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	356.69	6.13	6.13	4.24	0.47	2.36	1.18	0.24	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	240.99	3.07	6.95	2.42	1.29	1.29	0.81	0.65	0.97	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	315.42	3.98	3.44	1.63	0.36	1.45	0.90	1.09	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	268.80	2.51	2.51	2.93	1.26	0.21	0.42	1.05	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	257.71	2.34	2.93	2.93	1.37	0.39	0.39	0.20	1.76	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	253.45	2.53	4.64	3.38	0.63	0.21	0.21	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	427.52	4.78	7.75	2.64	1.15	1.15	0.33	0.66	0.99	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	262.35	5.05	5.80	2.99	1.12	1.12	0.00	0.75	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	271.53	3.26	4.60	3.07	1.34	2.11	1.53	1.34	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	299.01	3.27	7.56	2.45	2.04	2.04	0.41	0.61	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	289.54	1.81	2.01	3.02	1.01	1.01	0.81	0.60	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	373.28	3.78	3.78	3.24	0.54	0.54	0.81	0.81	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	306.56	3.84	4.80	2.88	0.24	1.68	1.20	0.48	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	271.96	3.76	2.59	4.00	0.71	1.18	0.71	0.47	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	373.74	3.07	3.81	3.51	0.73	1.17	0.29	0.88	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	291.88	3.80	5.69	3.16	1.05	1.48	0.63	0.63	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	286.02	2.45	3.32	2.10	1.22	1.57	0.87	0.52	2.27	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	346.33	3.81	4.22	4.42	0.80	1.41	0.60	0.00	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	311.75	4.89	7.21	3.02	1.86	3.26	1.40	2.33	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	284.05	2.40	3.36	2.88	2.16	0.24	0.48	0.72	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	301.92	2.68	4.17	4.17	0.30	0.60	0.60	0.89	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	292.28	2.87	2.63	2.39	0.48	0.96	0.24	0.24	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	275.59	4.65	4.65	3.44	1.62	0.81	0.20	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	296.77	3.89	7.99	2.25	0.61	0.82	0.82	1.23	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	305.10	6.00	8.67	2.00	2.89	0.67	1.56	0.89	0.89	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13628.39	153.91	685.62	0.00	13.99	55.97	83.95	41.98	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	258.69	2.48	3.55	3.90	2.13	0.71	2.48	1.06	3.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	251.52	1.66	1.99	2.65	0.99	0.33	0.33	0.33	1.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1710.59	44.46	109.06	0.84	0.84	18.46	10.07	15.94	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	492.77	5.05	17.45	2.76	0.46	2.76	0.92	0.92	2.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	288.46	2.59	2.59	4.21	0.97	0.65	0.65	0.65	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	207.15	2.57	4.82	3.85	0.64	0.32	0.96	1.28	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	507.02	4.40	9.12	1.89	1.57	1.26	0.31	0.94	1.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	186.84	0.71	0.71	2.82	0.71	0.00	0.71	1.41	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	180.57	1.68	2.24	1.68	1.12	0.56	0.56	1.12	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	603.48	40.60	23.09	0.00	0.00	6.37	3.18	3.18	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	328.56	8.83	7.81	2.04	1.02	2.04	0.68	2.38	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	184.88	6.17	0.97	3.25	1.62	0.32	0.32	0.97	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	218.31	0.35	4.61	4.97	0.71	1.06	2.48	0.71	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	12543.21	323.28	598.07	0.00	0.00	113.15	16.16	80.82	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	9208.46	157.95	410.67	7.90	0.00	86.87	23.69	7.90	7.90	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	327.12	2.93	4.88	1.46	0.98	0.49	0.98	2.93	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	369.92	1.98	5.45	2.48	0.00	1.49	2.98	2.48	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	361.22	4.22	4.69	2.35	0.00	0.47	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	497.11	5.30	6.29	0.66	0.66	0.66	2.32	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	341.51	3.71	5.57	3.09	0.00	0.93	2.78	2.17	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	353.44	3.67	6.42	1.22	0.61	0.92	1.53	1.83	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	286.83	0.63	1.58	0.32	0.79	0.32	0.48	0.48	1.58	0.00
Adipocyte - breast, donor2	11327-117E4	261.50	3.53	11.39	0.32	0.80	1.44	0.80	0.32	0.96	0.00
Adipocyte - omental, donor1	11473-119C6	333.85	1.15	2.04	0.38	1.27	0.25	0.89	0.25	2.04	0.00
Adipocyte - omental, donor2	11474-119C7	195.84	0.75	0.75	0.00	0.00	1.49	0.00	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	182.53	0.33	1.67	0.33	0.67	0.33	0.00	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	175.45	0.00	1.28	0.00	0.64	0.64	0.00	0.00	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	90.16	0.00	0.00	0.00	1.10	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	313.43	1.35	2.26	0.90	1.81	0.90	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	107.22	2.09	3.13	0.17	1.22	0.17	0.35	0.00	0.87	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	289.84	0.78	0.39	1.17	1.56	0.00	0.59	0.00	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	238.33	0.26	2.06	1.03	1.03	0.00	0.51	0.00	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	562.28	2.79	1.95	0.28	2.79	0.56	0.84	2.23	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	350.34	1.18	1.18	1.18	2.94	0.59	0.59	0.59	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	954.66	1.53	2.98	0.72	1.45	0.72	0.80	0.88	1.69	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	436.36	2.58	2.26	1.29	0.32	0.00	0.65	1.61	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	329.51	0.53	2.67	1.07	0.53	0.53	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	469.08	2.78	2.23	0.00	0.56	0.56	1.11	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	304.02	2.08	2.08	0.00	1.25	0.00	0.00	1.66	3.74	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	339.58	1.00	1.51	0.25	0.75	0.50	0.00	0.50	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	363.90	1.64	1.31	0.65	2.29	0.33	0.33	0.33	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	440.27	2.74	1.22	0.00	0.30	0.91	0.61	0.91	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	132.16	0.00	0.22	0.66	0.22	0.00	0.00	0.00	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	35.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	1.20	0.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	81.32	0.18	0.36	3.06	0.36	0.00	0.18	0.00	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	40.16	0.00	0.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	44.99	0.41	0.21	2.26	0.00	0.00	0.41	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	262.26	0.57	2.40	2.17	1.72	0.23	0.11	0.00	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	141.31	0.00	0.98	1.22	1.96	0.73	0.49	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	453.79	2.70	16.17	0.90	0.00	3.15	1.35	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	465.83	5.21	22.14	1.30	0.43	1.74	0.00	0.00	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	365.98	6.42	25.68	2.14	2.14	8.56	4.28	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	445.39	4.18	21.82	1.20	1.79	0.30	0.60	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	522.30	1.26	26.56	0.00	1.26	0.00	0.00	0.00	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	282.51	3.30	13.20	0.00	0.00	1.32	0.66	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	390.51	1.95	12.35	0.32	0.65	1.30	0.32	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	416.51	2.91	16.02	0.00	0.97	0.97	0.00	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	327.82	4.75	12.47	0.59	0.00	1.78	1.78	0.59	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	456.11	6.03	19.59	0.38	0.38	2.64	0.75	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	373.00	4.35	7.98	5.08	0.00	2.18	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	218.16	2.51	8.78	1.25	3.76	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	535.56	0.33	1.32	1.98	1.48	0.00	0.16	0.16	0.66	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	335.74	4.09	17.74	1.36	0.00	2.73	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	390.85	1.06	2.26	0.45	0.60	0.30	1.06	0.15	0.90	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	393.27	4.82	13.93	1.07	1.07	2.68	0.54	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	332.72	2.83	6.05	1.70	0.38	2.27	0.57	0.76	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	349.88	9.89	16.04	1.07	0.53	1.34	1.60	0.27	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	255.57	5.85	7.80	0.00	0.00	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	376.50	1.82	3.32	1.66	0.33	1.00	0.50	0.33	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	266.56	2.40	7.20	3.60	1.20	2.40	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	269.05	0.00	3.54	3.54	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	376.34	6.18	13.21	1.37	1.37	2.40	0.34	0.34	1.03	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	213.94	0.00	8.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	398.05	2.43	11.65	0.49	0.00	0.00	0.97	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	434.47	2.28	7.97	1.14	0.38	3.04	1.52	0.76	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	283.46	3.63	13.33	2.42	0.00	2.42	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	393.89	2.85	8.55	1.14	0.57	0.00	0.57	0.57	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	319.17	2.99	6.63	0.43	1.07	1.50	0.86	0.21	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	260.15	4.13	5.68	0.77	1.03	1.29	1.03	0.26	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	400.23	4.22	9.38	0.47	0.94	2.35	0.00	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	381.04	8.68	16.40	0.32	0.00	2.57	1.61	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	286.09	2.85	4.99	0.00	0.71	1.43	2.85	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	367.35	4.09	17.55	1.17	0.58	2.34	1.75	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	373.03	7.23	8.13	0.90	1.20	0.90	0.30	0.00	1.20	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	248.29	4.75	8.32	0.00	1.19	1.19	1.19	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	494.83	4.58	23.39	1.02	0.00	1.02	1.53	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	446.21	7.64	18.59	0.76	0.76	2.55	0.51	0.25	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	297.35	1.27	1.27	0.00	0.00	0.00	0.64	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	396.58	2.16	10.36	0.00	0.43	0.86	0.00	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	358.38	2.54	6.14	1.06	0.85	1.91	0.64	0.21	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	267.94	3.48	10.15	1.16	0.87	2.03	0.87	0.29	1.16	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	377.89	2.83	16.06	0.94	0.00	1.89	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	352.61	3.73	7.46	0.68	0.17	1.02	0.00	0.85	1.02	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	238.59	6.95	18.53	0.00	0.00	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	340.12	2.11	8.45	4.23	4.23	0.00	0.00	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	353.99	1.93	6.00	0.86	1.29	0.64	0.64	0.43	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	303.84	5.41	4.81	0.00	1.20	1.20	1.20	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	408.23	1.46	8.75	0.73	0.73	0.00	0.73	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	397.69	1.15	9.88	0.69	2.53	1.84	0.23	0.46	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	354.49	12.75	43.36	0.00	0.00	5.10	2.55	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	470.07	0.00	2.29	1.78	0.25	0.51	0.25	0.76	1.27	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	374.27	4.34	7.64	0.83	0.41	0.83	0.41	0.62	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	319.77	8.57	13.46	0.61	0.31	2.14	0.92	0.61	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	463.67	5.74	16.73	0.96	1.43	2.39	2.87	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	319.08	4.43	8.87	1.55	1.77	1.77	0.44	0.44	0.67	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	286.85	3.05	10.68	0.00	0.00	3.05	1.53	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	372.77	1.66	6.65	0.55	1.11	1.11	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	326.49	5.56	11.39	0.26	0.79	1.06	1.06	0.26	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	326.74	5.09	7.63	1.09	1.09	1.45	1.09	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	187.30	0.37	0.25	2.21	0.74	0.00	0.00	0.37	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	75.65	0.17	0.34	1.03	1.03	0.00	0.00	0.00	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	28.11	0.00	0.00	0.63	1.05	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	729.59	1.74	5.23	1.39	2.44	0.70	0.00	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	988.11	11.32	23.62	4.53	1.94	2.59	2.59	0.81	1.29	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	727.75	5.52	10.29	4.47	2.09	1.19	1.49	0.45	0.60	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1132.06	12.73	22.02	1.61	0.34	3.67	1.26	0.80	0.69	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1530.69	15.66	22.68	1.50	0.13	2.51	1.50	0.63	0.25	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1393.89	15.59	20.60	1.02	0.00	2.73	1.37	0.57	0.80	0.34
Basophils, donor1	12241-129G9	116.64	0.26	0.00	0.00	0.26	0.00	0.26	0.00	0.00	0.00
Basophils, donor2	12242-129H1	527.48	0.36	1.80	0.36	0.72	0.00	0.36	0.36	0.00	0.00
Basophils, donor3	12243-129H2	211.68	0.15	0.15	0.73	0.15	0.59	0.15	0.44	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	35.79	0.00	0.22	0.65	0.00	0.22	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	10.06	0.00	0.00	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	129.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	346.46	1.88	4.39	1.88	0.00	0.00	0.00	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	60.51	0.42	0.21	1.87	0.00	0.00	0.21	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	45.60	0.00	1.38	1.15	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	229.97	6.48	14.40	1.44	0.00	1.44	0.36	0.90	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1009.43	4.33	8.76	10.20	0.41	1.24	0.31	0.21	0.62	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	1000.32	9.55	14.21	7.69	0.23	2.56	0.47	0.23	0.00	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	675.68	0.32	1.60	0.96	2.24	0.32	0.32	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1065.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	228.24	0.56	1.69	0.00	0.00	0.00	0.56	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	211.03	11.14	10.58	0.56	0.74	0.74	0.56	0.93	0.00	1.30
CD14+ Monocytes, donor3	11381-118B4	195.39	6.81	8.12	0.00	0.44	1.54	1.10	0.66	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	489.95	1.98	1.70	0.57	1.70	0.28	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	480.29	1.14	0.76	1.52	0.00	0.00	0.38	0.76	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	532.89	1.31	0.66	1.31	1.31	0.33	0.99	0.33	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	196.44	3.32	4.05	0.14	0.14	1.01	0.58	0.14	0.00	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	267.95	7.24	5.43	0.30	0.30	1.21	1.21	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	394.43	9.71	5.21	0.24	0.24	0.71	0.71	0.95	0.24	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	258.13	4.85	8.04	0.00	0.17	1.34	1.67	0.67	0.00	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	428.37	12.42	12.14	0.00	0.28	1.93	2.21	1.66	0.55	2.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	782.71	13.88	14.63	0.00	0.25	3.72	0.00	1.24	0.74	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	472.08	5.87	11.94	0.00	0.00	2.74	1.57	0.39	0.00	1.76
CD14+ monocytes - treated with BCG, donor2	11870-125B7	501.03	11.93	12.46	0.00	0.00	2.31	2.14	1.07	0.36	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1321.89	5.22	7.18	0.00	0.22	0.87	1.52	1.09	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	546.22	5.85	6.79	0.00	0.00	0.94	0.70	0.70	0.47	2.58
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1013.81	17.95	20.07	0.53	0.00	2.64	4.75	1.06	0.00	4.22
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1154.84	14.42	19.97	0.00	0.00	4.44	0.00	1.11	1.11	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	207.21	7.73	6.40	0.00	0.00	1.19	1.19	0.59	0.15	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	401.09	8.98	7.58	0.20	0.40	2.39	0.80	0.80	0.40	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	902.54	7.08	4.79	0.21	0.00	0.83	0.42	0.42	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	276.60	4.35	8.01	0.00	0.00	0.92	1.14	0.69	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	572.97	6.11	2.49	0.00	0.00	0.45	0.68	0.45	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	668.22	10.04	10.04	0.00	0.00	2.62	1.31	1.31	0.00	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	260.92	1.61	4.84	0.00	0.27	0.81	0.81	1.08	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	452.03	15.18	10.99	0.17	0.00	2.97	2.62	0.70	0.35	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	611.45	18.52	13.89	0.00	0.00	2.52	1.68	1.68	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	211.45	4.78	9.19	0.00	0.00	1.10	0.92	0.37	0.00	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	361.78	9.51	6.69	0.00	0.00	1.76	2.11	2.82	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	527.79	16.67	9.21	0.44	0.00	1.75	0.88	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	479.70	12.90	20.23	0.00	0.00	4.71	2.27	1.57	0.17	3.31
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	563.09	23.04	36.05	0.00	0.00	6.69	2.60	4.46	0.00	2.97
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1201.26	5.82	7.54	0.00	0.22	0.86	1.08	0.86	0.43	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	233.41	6.55	5.73	0.00	0.00	0.41	0.00	0.00	0.00	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	555.62	3.48	2.55	0.00	0.00	0.46	0.70	0.70	0.00	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	761.86	4.64	5.34	0.00	0.00	0.46	0.93	0.00	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	379.04	0.44	2.18	0.00	0.00	0.22	0.22	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	367.74	0.92	2.77	0.00	0.23	0.23	0.46	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	322.54	0.00	1.52	0.22	0.00	0.43	0.43	0.22	0.00	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	310.82	0.00	2.80	0.00	0.31	0.16	0.31	0.31	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	272.45	0.17	1.22	0.17	0.17	0.00	0.35	0.35	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	469.57	2.90	1.56	0.00	0.00	0.22	0.67	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	289.11	0.77	0.51	0.00	0.00	0.26	0.00	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	306.73	0.66	3.73	0.00	0.00	0.22	0.22	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	351.61	0.21	1.47	0.21	0.21	0.21	0.21	0.00	0.00	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	308.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	299.67	0.00	1.36	5.42	0.68	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	318.96	0.00	3.11	3.11	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	424.83	0.00	2.13	3.20	0.53	0.53	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	428.32	0.00	1.61	2.68	0.00	0.00	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	295.52	0.70	0.70	4.21	0.00	0.70	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	312.96	0.78	0.78	0.78	0.78	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	363.85	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	297.53	5.75	13.97	2.47	1.64	0.82	0.82	1.64	0.00	4.11
CD19+ B Cells, donor2	11624-122B4	308.31	2.18	5.80	0.00	1.45	0.73	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	279.67	5.55	4.54	1.51	0.00	0.00	0.00	0.50	0.00	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	2246.56	3.23	11.72	1.62	0.40	0.40	0.40	0.40	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	1379.44	1.60	4.39	0.80	0.40	0.40	0.40	0.00	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	369.49	1.00	0.00	0.00	5.02	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	527.54	0.56	0.56	0.56	0.56	0.00	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	638.78	0.75	3.01	1.50	1.50	0.38	1.50	0.38	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	818.50	0.90	0.90	0.68	2.03	0.00	0.23	0.00	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	1214.35	6.07	7.86	1.43	0.00	0.36	1.07	2.14	0.00	1.43
CD4+ T Cells, donor2	11306-117C1	657.07	22.05	33.68	4.90	0.61	4.29	0.61	0.61	0.00	5.51
CD4+ T Cells, donor3	11382-118B5	701.18	21.65	20.74	1.22	0.00	3.66	1.52	1.22	0.00	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	486.23	0.51	1.79	1.53	0.26	0.51	0.77	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	505.34	0.67	2.25	3.37	0.22	0.00	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	371.69	0.29	0.86	1.72	0.29	0.00	0.00	0.57	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	552.79	1.42	1.90	0.95	0.00	0.00	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	528.15	0.00	1.40	2.81	0.00	0.70	0.70	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	405.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	408.40	0.72	2.46	0.87	0.14	0.29	0.43	0.14	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	353.50	5.25	7.12	2.20	0.17	1.19	0.68	0.34	0.00	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	309.84	3.06	6.77	2.10	0.32	1.61	0.97	0.32	0.00	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	540.65	1.34	5.83	2.24	0.00	0.00	0.45	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	541.20	0.35	3.14	2.80	0.00	0.35	1.05	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	590.45	3.08	6.60	2.64	0.00	1.32	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	440.61	0.00	2.95	0.84	0.42	0.42	2.11	0.84	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	272.59	4.36	6.23	2.08	0.00	2.08	0.83	0.21	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	216.18	1.67	5.35	1.67	0.33	0.33	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	496.55	0.82	4.89	2.99	0.00	0.27	0.54	0.00	0.27	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	574.54	0.54	3.22	2.68	0.54	0.00	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	308.43	0.00	5.38	1.79	0.00	0.00	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	620.26	1.85	4.08	1.85	0.19	0.37	0.74	0.93	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	502.12	1.52	2.82	1.95	0.22	0.22	0.22	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	435.01	1.26	2.31	2.31	0.42	0.42	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	578.41	0.51	6.07	0.51	0.00	0.00	1.01	0.51	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	595.72	0.43	2.17	1.30	0.00	0.00	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	845.05	3.49	7.41	0.87	0.00	1.31	0.87	1.31	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	595.33	0.99	0.49	1.98	0.49	0.00	0.99	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	505.91	0.00	0.92	2.77	0.00	0.92	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	457.83	0.00	1.40	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	892.26	0.83	0.55	2.49	0.28	0.00	0.28	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	982.55	1.23	2.94	0.98	0.25	0.49	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	477.40	0.00	0.00	10.78	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	579.43	2.51	1.79	1.43	0.36	0.36	0.36	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	574.77	1.38	2.77	1.38	1.38	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	914.09	5.57	3.93	3.93	0.00	0.98	0.33	0.33	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	520.35	15.02	25.53	0.75	0.00	4.51	1.50	1.13	0.00	5.26
CD8+ T Cells, donor3	11383-118B6	611.78	19.95	13.89	2.52	0.00	2.52	1.51	1.01	0.00	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	454.42	5.73	17.66	0.69	0.69	0.92	0.23	0.69	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	435.19	6.23	23.48	0.96	0.96	1.20	2.64	1.68	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	433.92	7.39	27.63	1.64	0.00	1.37	3.56	0.82	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	613.33	3.00	15.91	2.10	0.30	0.90	0.30	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	351.81	4.08	13.68	1.92	0.48	1.20	1.44	1.92	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	362.45	2.96	9.78	0.91	0.91	0.23	0.45	1.59	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	556.90	5.00	13.91	1.09	0.43	1.96	0.43	0.43	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	543.78	4.74	15.79	1.84	0.53	1.05	0.79	1.05	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	579.25	2.58	21.81	1.41	0.70	0.94	0.23	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	480.89	6.04	24.45	1.51	0.00	1.21	0.91	0.91	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	446.21	4.36	25.27	0.29	0.58	1.74	1.16	0.87	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	529.94	3.46	12.26	0.53	0.00	1.60	1.07	1.07	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	440.82	3.50	3.94	0.44	0.00	0.00	0.44	0.00	0.00	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	486.85	4.10	5.92	3.64	1.37	0.00	0.00	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	331.17	2.98	1.49	1.49	2.24	0.00	0.75	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	341.43	1.08	6.12	0.72	0.72	0.00	0.00	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	392.16	4.03	10.07	1.15	1.15	0.86	0.86	0.58	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	317.25	2.12	4.48	1.89	0.24	0.47	0.94	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	755.18	4.75	22.82	1.90	1.58	0.95	0.63	0.00	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	618.51	5.84	20.30	2.46	0.31	1.23	1.23	2.15	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	610.07	1.60	8.98	0.96	0.64	0.32	0.32	1.28	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	506.38	3.06	12.62	0.38	1.15	1.15	1.15	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	454.40	2.76	13.01	1.58	0.79	0.39	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	427.37	4.54	15.88	0.76	0.00	0.76	0.00	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	539.59	4.82	4.82	4.01	0.00	0.00	0.00	0.80	0.80	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	523.87	4.90	10.49	0.00	1.40	0.70	3.50	0.00	0.70	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	637.11	4.01	10.02	1.00	0.00	1.00	0.00	0.00	1.00	3.01
Cardiac Myocyte, donor1	11525-119I4	106.01	18.28	5.48	0.00	0.00	1.83	0.00	5.48	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	210.98	1.98	2.96	1.48	0.49	0.00	0.00	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	345.58	0.11	0.74	0.74	0.21	0.11	0.21	0.11	0.32	0.00
Chondrocyte - de diff, donor1	11261-116G1	547.39	4.16	3.81	0.69	0.00	0.00	0.35	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	174.13	0.00	0.71	1.42	2.49	0.00	0.00	0.00	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	207.08	2.16	6.60	1.37	1.71	0.46	0.34	0.11	0.80	0.00
Chondrocyte - re diff, donor2	11339-117F7	603.40	0.90	0.90	1.79	0.00	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	105.95	0.81	2.43	0.40	1.21	0.40	0.00	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	801.70	2.07	3.21	3.21	1.26	0.57	0.57	0.23	0.69	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	408.93	5.13	7.91	5.13	0.86	1.92	0.43	0.21	0.86	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	524.26	5.66	10.35	3.81	0.80	1.15	0.53	0.88	0.35	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	331.22	4.40	1.83	6.51	7.06	0.18	0.37	0.55	1.74	1.10
Corneal Epithelial Cells, donor1	11526-119I5	43.48	0.00	0.22	1.76	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	78.49	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	102.51	0.51	2.30	2.81	0.00	0.00	0.00	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	624.23	2.64	2.15	0.00	0.00	0.83	1.16	0.50	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	639.97	1.26	4.73	0.63	0.00	0.00	0.63	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	552.11	3.45	10.35	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	430.55	3.56	7.34	0.22	0.11	1.30	0.86	0.43	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	497.43	0.68	2.73	1.02	0.34	0.34	0.34	0.00	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	546.45	1.96	1.31	0.65	1.31	0.00	0.00	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	614.13	0.00	1.45	0.48	0.00	0.00	0.00	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	238.31	0.83	1.00	1.33	0.17	0.17	0.33	0.33	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	129.09	1.76	0.59	0.00	0.59	0.59	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	133.48	0.28	0.28	1.13	1.70	0.28	0.28	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	100.66	1.18	0.79	2.36	0.39	0.39	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	115.77	0.00	1.16	0.58	0.58	0.00	0.00	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	359.03	1.65	8.94	0.94	1.18	1.18	0.24	0.24	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	194.42	0.18	1.05	1.40	0.35	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	405.62	0.66	1.55	1.55	1.55	0.22	0.66	0.00	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	493.83	0.91	0.91	2.13	2.74	0.30	0.30	0.91	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	480.36	0.56	1.13	1.41	3.38	0.00	1.13	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	123.61	0.30	0.00	1.49	0.00	0.00	0.00	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	198.89	0.52	0.52	0.52	0.52	0.52	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	51.75	0.28	1.84	0.85	0.85	0.28	0.28	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	644.99	0.80	2.40	3.20	0.40	0.40	0.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	88.58	0.00	0.52	1.57	0.00	1.05	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	1191.40	3.48	5.09	2.48	1.86	0.37	0.87	0.50	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	418.88	2.39	5.00	0.65	1.30	0.43	0.65	0.87	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	852.94	3.66	4.89	3.91	1.34	0.49	1.71	1.83	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	123.99	0.00	1.14	2.28	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	101.98	0.00	0.00	2.10	1.40	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	159.05	1.88	2.83	1.88	0.16	0.00	0.16	0.00	0.16	0.00
Eosinophils, donor1	12244-129H3	381.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	467.02	0.00	0.00	0.00	1.65	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	581.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	40.56	0.00	0.00	1.95	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	0.00	0.00	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	239.74	5.75	3.28	0.00	0.82	0.41	2.87	0.00	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	192.92	3.28	2.30	0.77	0.44	0.88	2.30	2.30	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	182.66	0.76	2.49	1.95	0.54	0.00	0.43	0.22	0.11	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	681.47	1.33	5.94	3.03	0.36	0.85	0.36	0.24	1.33	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	1099.28	1.50	4.23	2.59	1.50	1.09	0.82	0.55	1.50	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	275.59	3.16	5.80	1.58	0.53	1.90	0.42	0.00	0.95	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	452.41	2.37	6.85	1.58	0.00	1.32	0.26	0.53	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	501.62	6.64	16.28	2.99	0.33	1.00	0.33	0.00	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	182.81	0.91	3.18	2.72	1.36	0.00	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	92.47	0.76	0.00	2.27	0.76	0.00	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	168.13	1.26	3.31	1.58	0.47	0.47	0.00	0.00	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	622.89	0.91	0.61	1.52	0.91	0.00	0.00	0.30	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	334.01	1.65	2.54	2.54	1.27	0.25	0.25	0.25	0.51	0.00
Fibroblast - Cardiac, donor6	11460-119B2	519.21	1.21	2.88	1.97	1.21	0.76	0.30	0.30	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	89.10	0.00	0.00	0.40	1.47	0.00	0.00	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	133.31	0.43	3.88	2.59	1.73	0.43	0.00	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	404.28	5.86	24.90	1.46	0.00	2.93	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	86.95	0.00	0.00	0.46	0.69	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	275.61	0.68	2.04	3.05	7.46	0.17	0.00	0.00	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	304.28	1.64	2.11	1.64	0.94	0.94	0.00	0.23	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	483.00	0.00	1.42	0.94	1.42	0.00	0.47	0.94	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	287.35	4.96	9.31	1.45	1.33	1.09	0.36	0.48	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	789.28	1.70	8.03	2.15	0.90	0.90	0.45	0.11	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	905.06	2.97	4.54	2.09	0.52	0.52	1.05	1.92	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	1166.69	2.60	8.12	1.30	1.30	0.81	0.65	0.32	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	607.82	1.87	0.83	1.25	1.25	0.83	0.42	0.42	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	455.09	3.14	2.88	0.52	0.79	0.79	0.52	0.26	1.31	0.26
Fibroblast - Gingival, donor2	11318-117D4	777.52	10.41	23.72	3.69	1.32	3.03	1.19	0.66	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	266.95	0.58	2.03	1.45	1.64	0.39	0.68	0.10	0.58	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	383.35	1.04	3.12	0.00	1.04	0.00	0.00	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	180.26	3.17	5.29	0.18	1.59	0.35	1.06	0.18	1.06	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	815.65	5.92	9.67	3.27	2.03	1.56	1.71	0.47	0.78	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	607.31	2.98	8.25	0.81	0.54	0.27	0.41	0.81	0.68	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	96.34	0.00	0.00	2.82	0.71	0.00	0.00	0.00	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	604.43	5.12	6.29	0.15	0.88	0.73	0.88	0.44	0.88	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	571.87	4.23	7.09	1.50	1.09	0.95	0.00	1.36	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	657.28	10.97	7.24	0.33	0.22	0.88	0.77	1.32	0.77	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	244.76	2.93	1.91	0.44	1.91	0.15	0.00	0.15	0.73	0.00
Fibroblast - Lung, donor1	11270-116H1	48.94	1.36	1.36	0.00	0.00	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	565.53	4.48	7.46	1.49	2.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	301.57	0.84	2.32	1.48	1.06	0.00	0.42	0.21	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	74.14	0.00	0.00	0.00	1.67	0.00	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	43.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	0.00	0.00	0.00	0.84	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	305.29	0.00	0.00	1.22	0.81	0.00	0.41	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	51.92	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	95.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	1262.77	3.10	8.92	2.33	1.55	1.36	0.78	0.78	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	1121.38	3.94	15.47	3.79	1.97	0.91	2.28	0.61	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	1586.54	1.22	0.00	5.20	1.53	0.00	0.31	0.61	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	413.68	0.76	2.67	1.14	0.76	0.00	0.76	1.14	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	298.88	1.62	5.40	0.81	1.35	1.35	1.08	0.00	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	224.64	1.04	1.39	0.58	1.28	0.23	0.58	0.12	0.46	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	710.28	1.11	2.10	1.77	0.33	0.77	0.00	0.00	0.77	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	143.05	0.00	0.20	0.41	0.20	0.00	0.20	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	90.88	0.00	0.67	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	163.68	1.58	1.19	0.40	1.19	0.00	0.00	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	940.64	6.35	16.27	0.99	2.38	2.58	0.20	0.99	0.99	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	364.65	0.36	3.02	0.71	3.73	0.89	0.18	0.53	1.07	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	659.45	3.15	4.34	0.59	2.17	0.59	0.00	0.00	0.99	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1001.25	6.62	9.93	3.91	0.90	0.60	0.60	0.60	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	1097.33	1.30	4.75	2.70	2.59	0.54	0.22	0.32	0.43	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	668.37	2.28	4.56	1.27	2.78	1.01	0.00	0.00	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	443.01	1.48	3.28	1.97	1.64	0.00	0.16	0.00	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1296.48	5.21	10.43	1.80	0.40	4.01	1.60	0.80	0.60	1.00
Fibroblast - skin normal, donor2	11561-120D4	713.18	0.90	3.32	1.61	0.60	0.10	0.10	0.00	0.50	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	1105.89	6.35	14.81	2.72	1.21	2.12	0.00	0.60	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	546.12	1.08	1.74	2.90	7.37	0.25	0.25	0.41	0.83	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	691.15	1.20	5.98	0.68	3.76	0.51	0.17	0.00	0.51	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	740.29	2.96	8.54	0.99	0.99	2.30	0.66	0.33	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1075.55	1.17	4.58	1.60	1.38	0.64	0.00	0.21	0.85	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	652.96	2.70	5.90	2.02	1.35	0.34	0.34	0.17	1.18	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	308.62	2.04	2.82	0.78	0.47	0.78	0.63	0.00	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	12010.61	22.16	132.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	255.36	2.61	0.87	4.36	3.49	0.87	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	625.99	0.87	2.95	4.51	0.00	0.17	0.69	0.69	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	903.04	2.08	2.60	3.38	0.26	0.78	0.52	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	987.56	2.30	0.26	5.62	0.51	0.26	1.28	1.02	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	632.35	3.83	6.12	0.77	0.00	0.77	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	862.03	7.66	14.68	2.55	0.00	3.19	2.55	0.64	3.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1453.13	28.53	58.19	3.71	0.29	13.69	3.42	2.28	1.43	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	494.98	19.85	18.20	6.34	0.00	3.58	1.93	2.48	1.38	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	456.20	15.75	12.79	3.88	1.37	4.34	1.60	0.46	0.68	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	917.54	30.12	35.07	2.38	0.40	9.71	1.78	0.79	1.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	519.42	17.18	19.03	2.64	0.26	3.44	0.79	0.00	1.85	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	452.69	14.35	8.48	4.57	0.98	3.26	1.96	0.33	0.98	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1282.45	52.18	99.50	2.21	0.00	19.46	3.54	3.10	0.88	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1081.54	6.78	10.32	2.97	0.00	1.41	1.27	2.12	1.70	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	999.42	11.82	23.03	2.71	0.74	2.96	1.72	2.71	1.60	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	965.71	11.82	22.30	3.49	0.00	3.22	2.95	1.88	2.15	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	752.78	6.69	12.88	2.48	0.99	2.11	0.74	0.87	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	853.40	5.95	13.98	3.05	0.69	1.11	1.38	0.55	0.97	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	748.15	9.76	16.06	2.44	0.00	2.24	1.63	1.02	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	590.75	5.48	7.30	1.83	0.91	1.14	0.68	0.91	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	906.96	6.48	21.05	1.99	0.75	1.12	1.00	0.87	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	653.76	6.12	12.90	2.62	0.22	0.66	0.44	2.19	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	510.59	4.73	5.91	2.36	2.66	2.66	0.89	0.89	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	701.96	7.47	18.76	2.38	1.91	2.38	1.59	1.91	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	616.41	7.37	8.71	2.68	1.12	1.34	0.67	0.89	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	502.67	7.06	14.52	4.23	2.62	1.61	1.81	0.40	0.60	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	858.39	7.63	15.61	2.88	2.37	1.70	0.85	1.02	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	1053.78	1.68	3.55	3.28	1.51	0.27	0.80	0.44	1.24	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1075.00	1.87	1.04	3.75	5.41	0.31	0.42	0.21	1.25	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	1091.09	1.71	1.20	2.39	6.83	0.51	0.68	0.85	1.20	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	620.21	5.42	8.96	2.21	2.55	1.22	0.77	0.66	1.22	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	890.45	1.58	3.91	3.00	2.00	0.33	0.42	0.42	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	852.05	0.82	2.86	3.88	1.63	0.20	0.41	0.41	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	519.48	3.71	6.81	2.27	1.65	1.65	0.83	0.83	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	591.57	5.19	10.72	2.19	1.84	1.15	0.69	0.58	0.46	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	542.99	4.00	9.34	2.50	2.84	0.67	0.50	0.50	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	475.69	4.63	10.58	0.88	1.98	1.32	0.22	0.66	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	805.60	7.99	11.81	2.71	2.95	1.48	0.86	1.72	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	610.44	7.94	17.67	1.62	2.11	2.11	1.62	1.62	0.65	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	584.02	8.02	16.04	1.92	5.13	1.60	0.32	0.32	0.96	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	561.14	4.93	12.60	2.18	1.90	1.61	0.66	0.95	0.38	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	536.53	6.17	9.02	1.74	1.11	0.95	0.79	1.11	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	501.14	6.39	10.64	2.74	1.22	2.43	1.22	0.61	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	648.14	7.00	13.07	2.09	2.93	1.46	0.73	0.52	0.63	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	480.61	4.83	7.90	0.88	1.54	2.63	0.44	0.44	1.32	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	501.34	7.57	13.75	4.77	2.24	0.84	1.96	0.56	0.28	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	608.11	8.33	5.83	1.85	1.39	1.48	1.02	1.85	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	602.73	5.35	10.96	1.07	1.34	1.87	0.80	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	606.51	6.73	13.01	2.14	1.53	1.68	1.53	1.07	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	627.48	7.38	11.66	1.68	0.65	1.42	1.17	0.26	0.78	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	537.81	4.88	2.71	1.36	1.90	0.27	0.54	0.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	443.18	5.53	12.54	2.77	2.21	1.66	0.74	0.55	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	415.60	2.41	6.14	3.95	3.95	0.66	1.32	0.88	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	685.30	1.98	1.98	1.98	3.97	0.00	1.98	3.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	371.73	1.98	4.75	2.64	2.24	1.32	0.92	0.53	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	366.79	4.64	9.08	1.61	3.83	1.61	1.61	1.41	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	811.53	1.52	0.25	5.59	7.37	0.25	0.51	0.51	1.27	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2009.11	10.35	10.35	2.19	0.20	0.80	0.80	1.19	5.18	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1450.17	19.72	26.04	2.93	0.15	3.39	2.31	1.85	3.24	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1052.17	12.48	7.36	4.71	0.82	1.64	1.02	0.41	5.52	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	598.95	0.94	0.94	4.69	0.00	0.00	0.31	0.31	1.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	613.71	1.13	4.80	4.52	0.00	0.57	1.41	0.28	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	577.43	13.84	8.76	7.38	0.92	2.77	0.46	0.46	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	1088.91	9.90	47.02	2.47	0.00	0.00	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	953.48	12.38	12.76	8.12	0.39	2.32	1.55	1.55	1.55	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	561.56	14.44	9.63	4.81	0.00	0.00	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	685.10	15.65	46.95	8.69	0.00	3.48	3.48	1.74	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	854.71	13.02	18.55	5.21	0.33	1.95	0.65	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	782.42	14.00	20.18	5.35	0.41	2.47	0.41	1.65	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	699.78	46.65	66.65	3.33	0.00	10.00	3.33	3.33	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	735.19	8.11	13.70	6.43	1.40	2.52	0.28	0.84	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	763.51	13.07	15.03	3.92	0.33	1.63	0.65	1.96	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	595.57	22.65	40.26	7.55	0.00	6.71	3.36	0.84	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	688.31	6.68	10.81	6.04	1.59	2.54	0.64	0.32	0.95	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	774.43	8.49	16.98	6.79	0.34	3.40	0.00	0.34	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	680.74	4.18	29.23	12.53	0.00	2.09	0.00	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	589.31	4.58	13.74	8.02	0.57	3.44	1.15	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	385.37	6.22	9.77	4.14	0.30	1.18	0.30	0.30	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	786.08	18.64	59.30	1.69	0.00	8.47	5.08	5.08	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	794.86	11.60	24.85	6.63	1.24	0.41	2.49	1.24	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	754.13	7.82	12.66	4.14	0.92	2.76	1.15	0.69	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	489.97	0.00	36.88	0.00	0.00	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	468.60	10.38	8.46	3.84	1.15	1.15	0.38	0.38	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	452.77	7.50	8.15	2.93	1.30	1.96	0.33	0.65	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	382.58	6.02	5.35	4.01	1.34	0.67	1.34	0.00	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	462.71	3.08	5.78	3.47	1.93	0.39	0.00	0.39	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	523.78	9.59	11.64	3.42	0.00	0.68	0.34	0.68	3.08	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	569.02	29.82	24.85	7.45	4.97	0.00	0.00	2.48	2.48	12.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	464.77	5.19	12.27	3.77	0.47	0.94	0.00	0.47	0.47	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	362.70	4.83	9.05	2.41	3.02	0.60	0.60	0.60	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	448.65	8.14	6.61	4.58	2.03	0.51	0.00	0.51	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	473.82	7.98	13.56	1.20	3.19	3.19	0.80	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	405.04	3.45	6.41	6.91	1.48	0.49	1.48	0.49	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	370.66	16.53	8.26	3.54	2.36	3.54	0.00	0.00	0.00	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	413.08	5.25	8.17	3.50	0.58	0.58	0.00	0.58	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	478.38	7.02	4.39	4.83	3.07	1.32	0.88	0.88	0.88	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	336.53	7.63	7.63	2.54	2.54	3.39	0.85	0.85	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	179.07	5.37	4.18	1.19	2.39	1.19	1.79	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	409.55	5.82	8.73	3.40	0.00	1.46	0.49	0.00	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	114.13	0.00	0.00	0.00	2.28	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	172.98	2.08	8.32	1.66	1.66	0.83	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	140.56	1.12	1.12	1.12	1.12	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	262.93	4.12	6.34	3.17	4.76	0.95	0.32	0.32	1.90	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	216.81	1.25	0.84	2.92	2.51	1.25	0.84	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	883.54	6.96	16.94	1.86	0.58	1.62	1.28	0.81	1.28	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	915.41	5.06	20.59	2.36	0.68	2.70	1.86	1.18	1.01	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	1019.90	8.87	17.52	1.59	0.00	4.55	1.14	0.23	1.59	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	859.82	6.34	17.71	1.53	0.33	2.73	2.08	0.87	0.66	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	888.45	5.16	16.12	2.58	0.64	0.86	0.64	1.29	0.86	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	975.66	7.75	14.42	1.08	0.22	1.72	1.08	1.29	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	836.77	7.22	21.54	1.99	0.25	3.49	1.87	1.00	0.62	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	845.91	7.72	14.75	1.20	0.17	2.40	1.72	0.34	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	824.32	7.37	13.46	1.60	0.00	1.92	1.28	0.00	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	52.04	0.00	0.00	1.12	1.12	0.00	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	27.70	0.00	0.00	1.30	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	203.57	7.93	7.93	0.00	5.29	0.00	5.29	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	55.38	0.35	0.71	0.71	0.35	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	34.87	0.73	0.73	0.73	0.73	0.00	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	438.32	2.97	8.22	1.05	0.17	0.35	0.35	0.17	0.52	0.00
Hepatocyte, donor1	11523-119I2	256.65	6.05	4.84	0.00	0.00	1.21	0.00	3.63	1.21	1.21
Hepatocyte, donor2	11603-120I1	530.05	10.77	7.54	0.00	0.00	0.00	1.08	1.08	5.39	2.15
Hepatocyte, donor3	11684-122I1	412.91	23.31	21.47	1.23	1.84	4.91	1.23	4.29	1.23	12.27
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1144.81	16.97	28.07	0.65	0.65	2.61	0.65	1.96	2.61	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	873.73	1.22	5.77	4.19	0.00	0.70	0.00	0.17	0.70	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	659.55	3.70	5.21	0.96	0.55	0.69	0.41	0.27	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	140.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	100.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	163.36	1.38	0.00	2.77	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	87.59	0.00	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	166.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	146.09	0.00	0.00	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	245.27	0.00	3.25	1.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	160.06	0.00	0.00	1.67	0.00	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	112.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	154.85	0.00	1.32	1.32	0.00	0.00	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	184.04	0.00	1.11	0.00	0.00	0.00	0.00	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	120.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	288.48	0.63	2.52	1.89	0.00	0.00	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	208.79	1.55	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	219.65	0.00	1.29	0.00	0.00	0.00	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	125.57	0.00	0.00	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	250.98	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	131.40	0.00	0.00	1.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	290.93	0.80	1.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	147.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	247.82	0.00	0.94	0.00	0.00	0.00	0.00	0.00	1.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	153.28	0.00	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	293.78	0.00	2.15	0.00	0.00	0.00	0.00	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	134.67	0.00	0.00	0.00	0.00	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	147.87	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	186.84	0.00	1.28	1.28	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	158.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	205.46	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	179.23	0.00	0.00	0.71	0.00	0.00	0.00	0.71	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	139.37	0.00	0.00	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	320.70	0.31	5.25	0.31	0.00	0.31	0.31	0.62	1.23	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	180.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	229.45	0.00	0.00	3.14	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	257.99	0.00	0.70	1.39	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	53.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	155.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	76.73	0.00	0.00	0.87	0.00	0.00	0.87	0.00	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	49.50	0.00	0.00	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	66.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	51.21	0.00	2.13	2.13	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	120.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	162.43	0.00	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	144.51	0.00	0.00	0.92	0.00	0.00	0.00	0.00	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	38.07	1.06	0.00	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	388.33	0.82	1.96	3.26	0.08	0.33	0.24	0.24	0.24	0.00
Keratinocyte - epidermal, donor2	11349-117G8	49.19	0.59	0.00	1.76	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	537.84	7.48	19.22	4.07	0.28	3.12	0.66	0.38	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	831.06	1.14	4.88	3.63	0.00	0.23	0.45	0.23	0.00	0.00
Keratocytes, donor1	11527-119I6	77.36	0.34	0.00	0.00	0.69	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	75.00	0.00	1.17	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	181.39	1.38	6.52	1.38	1.58	0.59	0.20	0.59	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	481.34	2.20	2.20	4.40	0.00	0.00	2.20	13.19	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	400.21	2.16	8.63	1.08	0.00	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	590.85	1.73	4.73	2.08	1.15	0.23	0.23	0.35	0.92	0.00
Lens Epithelial Cells, donor3	11690-122I7	453.39	0.20	1.11	3.63	1.41	0.20	0.20	0.20	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	239.53	0.95	1.07	1.30	0.59	0.00	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	117.21	0.56	2.79	1.40	0.00	0.84	0.00	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	326.94	9.13	18.42	1.26	1.10	2.36	0.63	0.47	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	146.80	2.69	3.23	0.54	0.54	0.00	0.54	1.08	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	70.28	3.15	2.52	1.26	0.95	0.63	0.00	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	86.04	2.26	4.42	0.43	0.22	0.75	0.22	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	234.33	4.10	7.39	1.23	1.23	1.23	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	41.46	0.51	0.76	0.00	0.76	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	104.01	3.52	6.05	0.56	0.56	0.70	0.00	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	247.60	2.37	5.93	0.00	0.79	0.00	1.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	200.28	3.30	8.34	0.39	0.00	1.16	0.00	0.58	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	34.07	0.74	0.93	0.37	0.37	0.19	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	197.90	3.14	7.32	0.00	0.00	0.70	0.35	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	134.77	1.91	5.49	0.72	0.72	0.24	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	88.45	3.57	5.22	0.41	0.27	0.69	0.14	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	265.46	3.70	9.55	0.92	0.62	0.92	0.00	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	57.67	0.31	1.25	0.94	0.00	0.31	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	96.80	1.10	3.29	1.10	0.37	0.55	0.00	0.18	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	218.20	1.97	9.54	0.33	0.99	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	63.85	2.05	2.34	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	44.06	0.75	2.24	0.50	0.00	0.25	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	302.13	4.85	9.21	1.45	1.45	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	173.97	3.23	7.00	1.35	0.54	1.08	0.27	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	120.65	1.97	5.00	0.45	0.45	0.30	0.15	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	155.52	2.07	4.67	0.52	0.52	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	252.32	5.65	10.05	0.84	0.63	1.68	0.21	0.63	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	100.45	2.41	4.66	0.00	0.60	0.45	0.15	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	195.36	3.44	6.19	0.00	1.38	0.00	0.00	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	155.60	1.13	3.39	0.56	0.56	0.38	0.38	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	63.83	1.27	1.91	0.74	0.21	0.21	0.00	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	227.75	5.33	13.08	0.97	0.48	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	110.48	1.32	4.30	1.32	0.66	0.00	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	64.42	1.49	2.48	0.50	0.50	0.37	0.00	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	338.37	3.70	9.26	1.11	1.11	1.11	0.37	1.48	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	166.29	2.96	6.18	1.73	0.49	0.00	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	57.61	1.51	2.75	0.41	0.00	0.55	0.27	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	293.01	3.86	7.08	1.61	0.64	0.96	0.64	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	267.20	3.04	10.96	0.00	0.00	1.22	0.61	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	210.09	4.48	9.24	0.14	0.42	1.12	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	237.51	3.20	6.76	0.36	1.42	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	61.57	0.97	2.91	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	42.79	0.31	1.24	0.78	0.16	0.16	0.00	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	175.83	2.86	5.73	0.72	0.72	1.79	0.36	0.00	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	109.76	0.33	0.65	0.33	0.00	0.00	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	33.43	0.94	1.41	0.24	0.24	0.00	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	256.91	0.62	1.73	1.24	0.99	0.25	0.25	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	58.91	1.54	1.54	0.51	0.51	0.26	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	73.10	1.19	2.98	0.30	0.00	0.00	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	179.01	0.00	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	164.17	0.00	2.30	0.77	0.77	1.53	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	165.52	1.48	0.74	2.23	0.74	0.00	0.00	0.00	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	132.02	0.42	1.69	6.35	0.00	0.00	0.85	0.85	1.27	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	109.72	1.41	2.81	2.11	0.70	0.00	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	96.20	1.87	0.00	3.74	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	120.57	2.58	6.18	0.00	1.03	0.52	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	110.62	2.38	0.00	5.95	0.00	1.19	0.00	0.00	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	171.45	0.00	0.00	2.94	0.00	0.00	0.00	0.00	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	330.96	3.49	5.82	3.49	0.29	0.58	1.45	0.00	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	356.09	3.15	10.35	3.60	0.00	0.45	1.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	234.26	0.14	0.41	4.74	0.14	0.14	0.27	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	139.16	1.03	3.59	4.11	0.00	0.00	0.51	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	316.51	2.12	4.59	3.18	0.00	0.00	0.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	270.52	0.67	6.66	1.33	0.00	0.67	0.00	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	183.38	2.55	6.11	4.58	0.00	0.00	0.00	0.51	1.53	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	353.25	1.87	6.94	3.47	0.27	0.53	0.53	0.27	0.27	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	375.81	2.83	7.56	4.35	0.38	0.76	1.32	0.19	0.38	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	157.07	0.00	3.07	5.52	0.61	0.00	0.61	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	182.65	0.00	5.71	3.26	0.00	0.00	0.00	0.00	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	403.16	3.96	7.29	3.54	0.00	1.46	1.67	0.83	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	376.39	3.36	12.05	4.20	1.12	1.12	1.40	0.28	0.84	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	200.92	3.09	3.09	1.03	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	385.23	3.19	10.74	5.23	0.58	0.58	0.87	0.29	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	348.55	3.89	7.17	1.49	0.00	0.00	1.20	0.00	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	346.34	3.32	4.98	2.21	0.55	0.55	0.55	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	168.97	2.12	2.12	3.53	0.00	0.35	0.35	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	264.05	2.21	5.90	3.32	0.37	0.00	0.74	0.00	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	164.63	0.00	2.30	6.91	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	186.12	1.92	1.54	1.92	0.00	0.00	0.00	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	170.97	1.70	5.10	2.26	0.57	0.00	0.00	0.00	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	196.91	0.00	1.64	1.64	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	133.76	1.81	0.45	1.36	0.00	0.00	1.36	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	212.57	1.44	5.03	0.00	0.00	0.00	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	301.00	2.24	3.73	4.48	0.00	1.49	0.00	0.00	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	172.79	2.23	4.46	2.60	0.00	0.00	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	314.88	2.15	6.46	4.31	0.00	0.86	1.29	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	208.94	0.86	4.28	2.57	0.00	0.86	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	250.55	1.00	4.33	4.00	0.33	0.33	0.33	0.33	0.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	161.69	0.00	1.81	3.62	0.00	0.00	0.00	0.00	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	116.60	0.71	1.42	4.27	0.00	0.71	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	199.70	1.37	3.44	3.44	0.00	0.69	0.69	0.00	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	165.85	1.61	4.29	3.22	0.00	1.61	1.07	0.54	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	165.65	0.67	3.37	6.06	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	211.50	1.85	4.82	2.22	0.00	0.74	1.48	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	241.89	1.16	0.00	5.81	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	123.76	0.00	0.00	5.29	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	200.48	1.20	3.60	2.40	0.00	0.80	0.40	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	101.04	0.73	0.00	2.91	0.00	0.00	0.00	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	111.91	0.00	0.77	5.37	0.00	0.00	0.00	0.00	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	110.49	0.49	2.47	4.44	0.00	0.00	0.00	0.00	2.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	92.21	0.00	0.00	1.88	0.94	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	115.15	1.01	1.01	0.50	0.00	0.50	0.50	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	109.50	0.45	1.80	3.60	0.00	0.00	0.90	0.00	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	91.22	0.00	0.00	1.72	0.00	0.00	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	137.61	0.89	1.78	3.56	0.00	0.45	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	129.43	0.39	1.56	3.13	1.17	0.39	0.78	0.00	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	125.35	0.00	0.66	2.64	0.00	0.00	0.66	0.00	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	151.01	0.00	1.04	5.19	0.00	0.52	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	139.58	0.44	3.94	3.06	0.00	0.44	0.88	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	229.79	2.80	5.59	3.91	0.00	0.56	1.12	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	158.99	0.88	2.65	6.62	0.00	0.44	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	202.11	2.31	5.79	3.86	0.00	0.39	0.77	0.39	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	185.33	2.03	4.05	6.08	0.00	0.51	1.01	0.51	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	193.69	2.40	4.81	3.36	0.00	0.00	0.48	0.48	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	190.82	1.19	2.78	3.58	0.00	0.00	0.40	0.00	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	165.88	2.43	7.29	1.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	179.15	1.38	0.69	4.84	0.00	0.00	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	184.30	0.38	3.80	4.94	0.00	0.38	1.52	0.38	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	170.42	2.07	6.20	4.13	0.00	1.03	0.00	0.52	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	157.21	1.21	3.63	4.23	0.00	0.60	0.00	0.00	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	219.61	1.58	3.49	3.49	0.00	1.27	0.63	0.00	1.90	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	109.28	0.53	1.60	4.26	0.00	0.00	0.00	0.53	4.80	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	99.99	1.15	0.00	1.72	0.00	0.57	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	128.04	1.03	1.03	3.60	0.00	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	121.66	1.41	0.00	6.37	0.00	0.00	2.12	0.00	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	125.98	0.00	1.70	0.57	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	139.78	0.00	1.66	7.07	0.00	0.42	0.00	0.42	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	131.55	0.00	3.92	4.70	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	151.99	0.84	1.67	3.76	0.00	0.42	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	138.46	2.32	1.86	2.32	0.00	0.46	0.00	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	120.43	0.00	2.01	3.35	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	206.37	0.53	1.07	4.28	0.00	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	122.44	0.00	1.21	2.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	96.36	0.92	0.92	3.67	0.00	0.00	0.00	0.00	2.75	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	140.48	0.89	0.00	1.78	0.00	0.00	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	135.63	1.14	0.57	1.71	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	105.07	0.00	0.00	2.30	0.00	0.00	0.00	0.00	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	316.27	1.64	4.92	3.83	0.00	1.09	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	131.85	1.34	0.89	3.12	0.00	0.45	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	196.01	0.00	0.00	3.64	0.00	0.00	0.26	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	153.18	0.00	0.00	3.32	0.00	0.66	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	153.82	0.00	0.00	4.16	0.00	0.00	0.00	0.00	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	456.51	0.68	1.14	0.46	0.46	0.00	0.23	0.46	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	639.16	1.10	2.20	0.00	0.37	0.55	1.10	0.73	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	424.70	2.75	4.98	0.52	0.26	0.66	0.66	0.52	0.26	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	468.36	1.06	1.06	3.72	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	835.20	1.58	7.13	3.33	0.32	1.27	0.32	0.32	0.79	0.00
Mallassez-derived cells, donor3	11930-125I4	1106.62	1.25	5.28	2.08	0.14	0.69	0.56	0.28	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	533.69	3.89	7.27	3.19	0.00	0.50	0.40	0.00	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	707.08	2.90	14.48	3.76	0.00	1.74	0.00	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	121.97	1.25	2.24	2.24	0.00	0.00	0.00	0.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	6502.09	4.07	2.71	2.71	0.68	0.00	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	797.11	2.49	5.30	1.84	1.30	0.65	0.22	0.54	0.00	0.00
Mast cell, donor2	11565-120D8	2694.18	6.54	6.84	0.89	0.59	0.59	1.78	1.49	0.30	5.05
Mast cell, donor3	11566-120D9	1418.28	3.15	2.03	1.35	1.58	0.45	0.90	0.90	0.45	1.35
Mast cell, donor4	11567-120E1	4168.78	5.67	2.66	1.42	1.60	0.71	1.60	1.42	0.53	6.21
Mast cell, expanded and stimulated, donor5	11940-126A5	1262.63	6.88	10.53	2.55	0.55	1.22	0.89	0.67	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	684.08	2.33	6.42	0.58	0.00	0.00	1.17	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	706.46	1.15	4.02	2.06	0.46	0.23	0.92	0.23	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	481.01	1.00	2.34	2.51	1.17	0.17	0.84	0.33	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	481.27	0.80	1.89	1.79	0.50	0.30	0.30	0.20	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	203.50	1.04	3.46	0.00	0.35	0.35	1.04	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	1106.61	2.10	7.03	2.97	1.01	0.58	0.65	0.07	0.36	0.07
Melanocyte - light, donor1	11274-116H5	137.28	1.65	0.24	0.71	0.71	0.24	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	62.79	0.68	0.68	1.36	0.68	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	45.10	0.00	0.00	0.87	0.00	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	1147.77	6.66	12.91	2.92	2.60	1.56	2.08	1.87	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	572.58	6.19	14.79	2.42	0.54	1.61	0.54	1.61	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	629.46	4.55	8.84	2.68	2.14	0.27	0.27	1.61	0.27	0.00
Meningeal Cells, donor1	11493-119E8	357.66	0.25	0.25	2.23	1.24	0.00	0.00	0.12	0.00	0.00
Meningeal Cells, donor2	11573-120E7	143.49	0.00	0.44	2.20	0.88	0.00	0.00	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	1309.89	1.06	6.28	3.18	1.06	0.41	0.49	0.08	0.33	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	1134.35	2.85	4.85	3.99	1.71	0.57	0.29	0.29	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	362.78	0.91	1.21	1.41	0.30	0.20	0.10	0.20	0.40	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	24.97	0.00	0.00	0.00	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	87.65	0.00	0.00	3.92	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	499.45	6.46	16.50	1.44	0.72	2.87	0.72	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	328.03	0.42	2.54	1.06	1.27	0.42	0.21	0.00	1.06	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	273.94	2.51	7.04	0.00	1.01	0.00	0.00	0.50	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	213.38	0.88	0.88	0.88	1.10	0.22	0.22	0.00	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	267.40	5.11	5.11	1.46	0.00	0.00	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	152.84	0.20	0.82	1.64	0.20	0.41	0.00	0.20	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	425.36	0.97	1.80	0.14	1.94	0.00	0.42	0.14	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	55.76	0.00	1.12	0.37	0.37	0.00	0.00	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	383.67	1.97	3.68	1.05	1.84	0.53	0.26	0.00	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	58.16	0.00	0.89	0.00	0.30	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	132.56	1.28	1.92	1.92	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	989.61	1.42	5.67	1.77	0.35	0.35	0.00	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	374.33	0.31	1.56	2.19	0.63	0.00	0.00	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	590.71	2.18	7.26	5.81	0.73	0.73	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	593.20	2.92	4.51	0.53	0.53	1.06	0.00	0.00	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	425.40	1.00	2.00	2.50	0.00	0.00	0.50	0.00	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	418.92	9.90	15.32	1.01	0.43	3.47	1.08	0.94	1.30	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	434.80	0.00	1.35	0.00	0.00	0.00	6.75	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	501.41	5.17	4.68	0.25	0.00	2.22	1.97	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	487.92	5.01	9.13	0.88	0.00	0.59	3.83	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	72.60	0.00	0.00	0.00	0.00	0.00	0.00	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	424.32	5.58	4.65	0.31	0.00	1.24	1.55	1.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	455.52	7.88	17.63	0.00	0.00	3.32	2.28	1.24	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	81.06	2.32	4.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	434.45	5.01	5.51	0.25	0.25	2.25	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	476.65	4.65	6.52	0.47	0.00	0.00	0.47	1.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	421.67	2.64	4.88	0.20	0.20	0.61	0.20	1.02	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	366.66	6.73	12.67	1.19	0.00	0.79	4.36	1.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	94.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	283.18	3.54	7.96	0.00	0.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	490.12	4.56	17.86	0.76	0.00	1.52	0.38	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	96.06	0.00	5.26	0.00	0.00	2.63	0.00	7.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	353.78	4.88	9.34	0.00	0.00	1.49	1.27	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	187.85	0.00	2.76	0.00	0.00	0.00	1.84	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	291.80	4.77	4.47	0.89	0.30	0.89	2.38	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	226.35	1.68	6.71	0.00	0.00	1.68	3.35	6.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	363.56	4.52	5.52	0.25	0.25	0.50	1.51	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	451.81	15.45	22.34	0.24	0.24	1.90	3.80	3.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	153.70	1.11	0.55	0.00	0.00	0.55	1.11	1.11	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	428.49	3.91	5.99	0.00	0.00	1.38	0.46	0.23	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	425.52	5.05	7.99	0.42	0.00	1.05	0.84	1.26	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	354.87	2.65	2.85	0.20	0.00	0.00	1.02	1.83	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	430.37	4.51	7.94	0.43	0.00	1.07	0.21	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	428.58	4.67	4.22	0.22	0.00	0.22	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	342.76	2.41	4.82	0.00	0.22	0.22	0.88	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	308.23	6.59	2.53	0.00	0.00	0.00	1.01	2.53	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	164.04	0.00	3.31	0.00	0.00	0.00	0.00	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	435.68	2.17	6.25	0.27	0.54	0.27	1.90	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	397.31	2.94	4.41	0.88	0.29	2.35	0.29	1.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	138.47	4.36	6.54	0.00	0.00	0.00	3.27	7.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	327.26	1.92	3.84	0.00	0.48	0.00	0.96	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	393.83	9.21	9.21	0.00	0.00	0.40	2.00	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	161.80	1.37	0.00	0.00	0.00	0.00	0.00	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	336.89	4.51	5.51	0.00	0.00	2.00	1.50	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	215.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	128.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	370.92	4.82	2.19	0.00	0.00	0.88	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	195.35	1.10	0.00	1.10	0.00	1.10	2.21	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	181.23	1.28	1.28	0.00	0.00	0.00	1.28	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	454.19	3.97	5.45	0.25	0.00	0.99	0.74	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	248.43	2.09	2.78	0.00	0.00	0.00	1.39	1.39	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	247.51	0.00	0.00	0.00	0.00	0.00	6.63	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	425.64	3.42	8.21	0.34	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	315.08	1.75	2.19	0.00	0.00	1.75	0.44	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	290.82	1.07	1.42	0.36	0.36	0.36	1.07	3.55	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	468.24	4.21	6.73	0.28	0.28	1.68	2.52	0.84	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	367.83	2.91	2.91	0.42	0.00	1.25	2.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	184.15	2.33	1.75	0.00	0.00	0.00	1.17	2.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	314.33	4.22	6.33	0.00	0.00	0.90	0.30	0.90	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	506.71	6.68	4.59	0.83	0.00	1.67	1.67	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	252.66	0.00	0.00	0.00	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	349.10	4.62	6.46	0.00	0.00	0.92	4.62	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	563.43	4.55	3.41	0.57	0.00	1.14	0.57	1.71	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	486.12	2.35	3.04	0.00	0.00	0.97	1.24	0.83	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	426.56	4.66	5.44	0.00	0.26	0.78	1.30	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	549.52	4.72	3.00	0.43	0.00	0.43	1.29	1.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	160.07	1.91	1.27	0.00	0.00	0.00	2.54	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	362.17	1.87	2.94	0.27	0.00	0.53	3.20	0.80	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	452.29	2.69	6.29	0.30	0.30	0.90	0.90	0.00	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	325.03	1.55	3.53	0.42	0.14	0.28	0.57	0.57	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	374.25	1.91	2.87	0.32	0.00	0.00	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	656.54	4.86	7.08	0.22	0.22	0.44	0.66	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	247.62	0.76	0.76	0.38	0.38	0.38	0.38	1.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	479.86	1.70	5.40	0.28	0.00	0.57	0.57	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	544.70	3.69	8.60	0.00	0.25	1.23	0.49	0.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	112.74	0.00	0.00	0.00	0.00	0.00	0.65	0.65	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	307.55	1.76	2.35	0.00	0.29	0.59	1.18	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	425.57	2.59	6.05	0.58	0.00	0.86	0.58	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	365.57	1.65	2.06	0.41	0.00	0.41	0.82	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	220.36	2.38	2.98	0.30	0.00	0.89	0.89	0.89	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	226.01	3.77	11.30	0.00	0.00	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	249.52	3.56	5.35	0.00	0.00	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	414.99	8.54	10.51	0.66	0.33	0.66	1.31	1.64	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	275.61	5.26	14.73	0.00	0.00	2.10	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	359.79	0.20	2.17	0.79	0.00	0.20	0.59	0.40	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	378.12	1.86	0.93	1.86	1.86	0.93	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	379.66	10.14	9.76	0.00	0.00	3.38	0.00	1.13	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	261.55	1.60	0.80	0.00	0.00	0.27	0.27	0.80	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	427.64	0.57	1.81	0.79	0.45	0.45	0.11	0.11	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	221.75	2.21	5.16	0.00	0.00	1.47	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	343.71	7.33	14.66	1.10	0.00	2.56	0.37	0.73	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	371.79	29.56	62.22	0.00	0.00	3.11	4.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	344.71	0.53	1.07	0.00	1.07	0.00	0.00	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	158.42	0.00	3.86	0.00	0.00	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	256.52	2.02	14.14	0.00	0.00	2.02	2.02	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	233.17	4.64	7.17	0.00	0.00	1.26	0.42	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2654.43	1.36	8.17	0.00	0.00	1.36	0.00	1.36	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	838.61	1.27	2.54	0.64	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1613.19	1.62	3.24	0.00	0.81	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	649.49	12.08	10.57	0.00	1.51	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	9975.66	11.42	0.00	5.71	5.71	5.71	5.71	0.00	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	11679.57	75.04	39.15	3.26	0.00	9.79	6.52	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	2233.66	23.76	9.50	0.00	0.00	0.00	0.00	4.75	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	2534.91	37.65	12.55	0.00	0.00	0.00	0.00	0.00	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	476.33	1.29	3.02	1.51	2.15	0.86	0.43	0.00	0.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	189.71	3.14	8.88	1.57	4.18	1.57	0.00	0.00	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	279.68	2.67	0.67	1.33	2.00	0.67	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	214.11	2.09	0.42	2.09	0.42	0.42	2.09	1.67	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	937.21	8.75	5.89	0.76	0.95	1.52	0.76	2.85	1.90	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	847.40	4.79	7.98	0.00	0.00	0.00	1.60	7.98	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	157.75	2.04	0.68	0.00	2.04	0.00	0.68	0.68	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	2028.76	16.54	56.97	1.84	0.00	3.68	5.51	7.35	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	159.46	2.51	2.93	1.26	0.84	0.42	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	315.65	2.32	1.16	1.39	0.93	0.23	0.00	0.00	1.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	175.38	1.35	0.27	1.35	1.89	0.00	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	347.73	4.41	3.15	1.05	2.10	0.00	1.68	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	10277.35	66.81	200.42	0.00	0.00	11.13	11.13	22.27	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	148.91	0.50	2.48	1.99	1.99	0.00	1.49	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	256.32	2.98	3.25	0.81	1.08	0.81	1.08	1.08	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	187.01	0.68	1.81	0.91	2.04	0.45	0.68	0.23	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	146.97	1.63	0.65	1.14	1.63	0.00	0.16	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	374.53	3.28	7.47	0.73	3.83	0.36	0.73	0.73	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	202.10	1.06	2.65	2.12	4.77	0.00	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	136.87	1.20	1.80	1.20	3.00	0.00	5.40	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	629.12	4.92	8.20	0.33	0.33	0.98	1.64	1.64	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	151.57	1.46	0.49	3.09	2.28	0.00	0.16	0.65	1.14	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	562.48	7.58	9.35	1.59	3.53	0.71	1.94	1.76	1.06	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	185.65	2.11	0.70	0.70	1.41	0.00	0.00	2.11	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	134.24	1.84	0.92	1.38	1.38	0.46	1.38	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	188.63	1.93	1.61	2.25	2.89	0.00	0.32	1.93	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	607.00	2.76	5.17	0.69	0.69	1.03	1.38	3.10	1.72	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1643.49	7.59	7.59	0.00	0.00	7.59	0.00	17.70	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	348.66	3.56	2.67	0.45	4.23	0.45	1.11	0.67	1.11	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	210.43	3.39	0.85	1.69	2.12	0.85	0.42	0.85	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	241.39	1.90	1.19	1.42	0.71	0.24	0.24	1.42	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	165.69	1.72	0.00	0.43	1.29	0.00	1.29	0.43	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	7673.60	36.11	81.25	0.00	0.00	0.00	0.00	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	142.29	0.67	1.00	1.33	4.67	0.00	0.33	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	160.96	1.35	0.90	0.00	1.35	0.45	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	161.10	1.19	1.59	0.00	2.38	0.79	1.59	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	157.87	1.86	2.79	0.93	3.71	0.93	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	209.62	0.76	0.38	0.00	1.89	0.38	0.00	0.76	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	138.83	0.98	0.98	0.98	1.96	0.33	0.00	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	101.97	1.31	0.44	0.44	2.18	0.00	0.00	1.31	0.87	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	328.81	3.62	2.26	0.00	2.26	0.90	0.90	2.71	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	141.99	3.53	2.65	0.00	0.88	0.00	2.65	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	171.53	0.66	0.66	0.00	0.66	0.00	0.66	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	153.28	0.99	0.50	1.98	4.96	0.50	1.49	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	116.38	1.53	0.38	1.91	1.15	0.38	0.00	0.38	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	235.91	2.42	3.93	1.51	4.54	0.60	0.60	0.60	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	310.54	3.98	2.87	0.44	1.77	0.22	0.22	0.66	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	130.11	0.68	0.68	0.00	0.00	0.00	0.68	0.68	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	2038.70	5.11	40.88	5.11	0.00	5.11	0.00	5.11	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	151.81	0.00	0.61	0.61	4.27	0.00	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	119.28	1.26	0.31	0.63	1.26	0.00	0.00	2.20	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	118.64	2.42	0.61	0.30	3.93	0.30	0.30	0.91	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	132.12	1.58	0.00	0.00	3.96	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	622.37	7.94	4.53	0.00	1.13	4.53	1.13	10.20	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	2043.39	35.41	70.81	0.00	5.06	5.06	10.12	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	545.86	1.24	3.23	0.99	0.25	0.37	0.50	0.25	0.75	0.00
Myoblast, donor2	11322-117D8	321.05	5.37	6.90	2.69	2.11	0.96	0.77	0.00	0.19	0.19
Myoblast, donor3	11398-118D3	594.79	0.50	3.20	2.86	1.18	0.17	0.67	0.84	1.18	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	528.71	13.28	8.46	1.46	0.00	1.46	0.88	0.73	0.29	1.17
Natural Killer Cells, donor1	11230-116C6	713.13	4.92	4.92	1.23	0.62	0.00	0.31	0.00	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	498.17	13.27	21.11	0.90	0.60	4.22	1.21	1.21	0.00	4.22
Natural Killer Cells, donor3	11387-118C1	493.08	15.09	19.51	1.84	0.74	1.84	1.84	0.92	0.18	4.42
Neural stem cells, donor1	11275-116H6	1449.22	10.53	6.90	2.90	2.90	0.73	0.73	0.73	1.09	0.00
Neural stem cells, donor2	11352-117H2	1879.43	3.85	1.93	23.11	25.03	0.00	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	794.25	7.97	13.65	21.62	20.48	0.00	0.00	3.41	2.28	1.14
Neurons, donor2	11574-120E8	975.76	1.98	7.93	24.00	18.27	1.54	0.66	0.44	0.66	0.22
Neurons, donor3	11655-122E8	636.36	23.02	25.49	13.15	13.98	1.64	3.29	3.29	1.64	0.82
Neutrophils, donor1	11233-116C9	450.08	5.57	6.50	0.00	0.00	0.00	1.86	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	168.13	8.70	5.80	0.00	0.00	2.90	2.90	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	561.36	1.83	2.44	0.00	0.00	0.00	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	369.62	1.78	2.85	0.95	3.32	0.12	0.12	0.12	0.59	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	79.45	0.33	2.93	0.98	2.60	0.00	0.33	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	204.96	0.40	2.01	1.20	1.20	0.00	0.00	0.20	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	198.22	5.23	7.43	0.69	1.79	0.55	1.38	0.55	1.24	0.00
Olfactory epithelial cells, donor2	11934-125I8	365.63	10.42	17.22	1.45	1.30	1.74	1.45	1.30	0.87	0.14
Olfactory epithelial cells, donor3	11935-125I9	254.71	5.33	5.90	2.50	1.14	0.91	1.14	0.57	1.36	0.00
Olfactory epithelial cells, donor4	11936-126A1	349.17	4.68	5.84	1.56	3.21	1.66	0.97	0.78	0.97	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	855.19	4.21	6.02	0.00	0.00	1.20	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	143.57	0.00	0.64	0.43	2.34	0.00	0.00	0.21	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	38.87	0.00	0.00	1.14	2.29	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	74.49	0.00	0.00	0.62	3.10	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	59.80	0.00	0.39	1.37	0.39	0.00	0.00	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	1068.93	5.62	11.24	0.70	2.81	0.70	1.40	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	225.36	2.67	3.55	1.42	0.53	0.18	0.71	0.18	1.07	0.00
Pancreatic stromal cells, donor1	11249-116E7	742.03	2.86	6.23	3.37	1.77	0.34	0.25	0.17	0.67	0.17
Pericytes, donor1	11491-119E6	22.70	0.00	0.00	0.33	0.67	0.00	0.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	18.79	0.45	0.00	0.23	1.13	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	52.49	0.61	1.02	1.63	0.41	0.00	0.00	0.00	0.20	0.00
Perineurial Cells, donor1	11499-119F5	516.85	0.90	2.83	1.70	1.13	0.79	0.11	0.00	0.34	0.00
Perineurial Cells, donor2	11579-120F4	460.79	1.20	1.10	1.38	0.55	0.37	0.28	0.09	0.37	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	618.35	2.55	2.23	2.23	0.96	0.32	0.32	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	268.61	2.20	5.88	0.49	0.00	0.24	0.49	0.24	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	336.61	2.20	2.33	0.65	0.39	0.52	0.39	0.26	0.39	0.26
Placental Epithelial Cells, donor1	11278-116H9	278.15	1.67	1.20	4.54	0.00	0.24	0.24	0.00	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	184.07	0.00	1.11	2.22	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	86.58	0.20	0.59	0.79	0.59	0.20	0.00	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	111.71	0.32	0.63	0.32	0.95	0.00	0.32	0.95	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	248.37	0.75	2.44	1.50	0.94	0.38	0.00	0.00	1.13	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	893.59	1.31	2.74	1.44	1.04	1.31	0.65	0.00	1.17	0.00
Preadipocyte - breast, donor2	11328-117E5	201.96	1.80	4.95	0.23	0.68	0.68	0.45	0.45	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	322.98	0.64	2.24	0.96	1.07	0.32	0.11	0.11	1.28	0.00
Preadipocyte - omental, donor2	11329-117E6	360.96	1.31	2.18	2.62	2.18	0.00	0.44	0.87	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	303.69	2.58	4.87	0.57	1.15	1.00	1.00	0.14	1.58	0.00
Preadipocyte - perirenal, donor1	11469-119C2	91.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	168.91	0.00	0.00	0.92	0.92	0.31	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	1043.52	19.83	38.43	4.78	1.77	4.60	0.35	0.00	0.89	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	363.39	2.04	4.60	1.70	0.85	0.34	0.17	0.17	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	1219.39	7.17	7.17	5.50	1.21	0.65	0.65	0.65	0.47	0.00
Preadipocyte - visceral, donor2	11357-117H7	551.30	3.22	17.03	1.38	0.00	0.46	0.00	0.92	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	616.70	4.70	11.08	2.19	0.94	1.99	0.52	0.31	0.31	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1230.20	2.56	11.77	6.18	0.15	0.75	0.60	0.15	0.60	0.60
Prostate Epithelial Cells, donor2	11331-117E8	342.33	2.03	6.77	3.79	0.00	0.27	0.95	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	186.35	3.86	8.70	5.63	0.06	1.10	0.55	0.37	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	588.41	0.68	3.30	1.03	0.46	0.34	0.23	0.23	0.68	0.00
Prostate Stromal Cells, donor2	11332-117E9	547.04	13.99	27.97	0.90	0.54	3.05	1.97	0.00	1.08	0.00
Prostate Stromal Cells, donor3	11405-118E1	239.94	2.82	6.05	0.52	1.15	0.83	0.21	0.21	0.42	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	85.04	0.00	0.00	2.19	0.36	0.00	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	626.92	1.52	4.99	3.26	0.62	0.76	0.69	0.28	0.14	0.00
Renal Epithelial Cells, donor1	11517-119H5	37.03	0.00	0.00	3.55	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	69.00	0.00	0.71	1.42	0.00	0.71	0.00	0.00	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	640.48	1.91	7.83	2.65	0.53	0.53	0.21	0.21	0.74	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.11	0.00	0.00	0.68	0.68	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	112.39	0.54	0.67	0.40	0.94	0.13	0.27	0.00	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	578.34	16.21	19.09	3.33	1.55	4.00	3.77	2.44	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	27.95	0.00	0.00	1.33	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	127.43	0.66	0.66	1.32	0.66	0.22	0.00	0.00	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	61.44	0.63	0.00	1.25	0.63	0.00	0.00	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	22.47	0.83	0.28	1.39	0.28	0.00	0.00	0.28	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	400.75	0.54	1.34	4.56	0.00	0.27	0.27	0.27	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	133.68	2.11	1.69	2.11	0.00	0.00	0.42	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	138.08	1.93	1.74	4.05	0.39	0.00	0.39	0.39	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1079.65	1.81	5.70	1.04	0.26	0.52	0.00	0.52	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	135.02	0.57	0.57	0.85	0.85	0.28	0.00	0.28	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	143.05	2.06	3.09	1.03	0.00	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	413.50	1.00	1.76	4.27	0.50	0.00	0.25	0.00	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	5313.49	24.59	27.40	7.62	7.75	2.00	4.54	6.82	5.21	6.82
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	391.31	4.47	4.47	4.47	5.36	0.89	0.00	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	1536.08	25.87	94.11	2.75	4.40	4.95	2.20	2.20	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	1819.63	11.02	30.16	1.16	5.80	1.16	0.58	2.32	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	1389.71	1.56	4.94	2.86	2.21	0.39	1.82	0.65	1.69	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	721.35	8.04	19.07	2.88	1.79	2.78	4.17	1.29	1.49	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	1064.19	2.90	6.02	4.57	3.46	0.22	0.89	0.89	1.67	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	1426.37	10.54	20.59	3.23	2.85	2.48	1.36	1.74	1.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	854.86	10.72	27.27	2.33	2.45	2.21	2.56	2.21	1.75	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	1130.47	32.59	53.16	4.62	1.85	4.85	0.92	2.54	1.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	767.51	5.75	14.38	2.88	2.19	1.64	1.92	1.78	1.78	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	957.41	11.35	27.08	3.03	2.12	3.63	3.03	1.97	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	801.52	0.18	1.97	5.38	2.33	0.18	0.90	0.36	1.97	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	722.30	4.59	14.35	2.58	1.43	1.43	0.86	0.57	1.29	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	785.97	7.19	19.96	2.47	1.82	2.79	1.93	0.86	1.07	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	774.00	9.74	16.37	3.32	1.99	2.21	1.11	1.11	1.55	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	785.54	3.63	8.41	1.91	3.25	0.96	1.34	1.34	1.53	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	812.29	4.47	11.65	2.70	0.93	1.02	2.33	1.77	1.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	1305.02	9.58	13.53	4.32	2.44	0.56	0.56	0.94	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	769.17	5.31	6.50	2.39	2.39	0.40	1.99	2.12	1.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	922.11	9.25	31.25	3.02	2.43	2.82	1.75	2.34	1.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	873.45	18.90	24.06	2.86	2.10	3.44	0.76	0.76	1.72	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	758.13	3.84	6.30	2.14	2.14	1.17	1.39	0.53	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	753.46	8.41	30.83	1.68	1.68	2.52	5.89	2.80	1.68	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	766.82	14.70	26.83	2.56	2.56	2.73	2.22	2.56	2.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	659.12	2.55	5.83	2.73	2.19	0.73	0.73	1.82	1.64	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	701.21	9.69	23.30	2.94	1.47	3.19	2.58	2.45	1.96	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	785.91	8.19	20.82	2.01	1.34	1.34	1.21	0.67	1.75	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	854.80	2.83	10.38	2.83	0.71	1.18	0.71	1.18	2.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	759.92	10.12	25.40	1.79	1.59	3.37	0.99	2.38	2.38	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	814.25	12.16	24.79	4.44	1.87	2.34	1.64	1.17	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	800.81	4.56	12.03	1.87	1.87	0.83	1.45	1.45	2.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	795.25	7.96	29.64	2.88	3.32	1.77	2.88	1.33	2.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	736.94	9.61	11.91	2.92	1.88	2.09	0.42	1.04	2.30	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	844.25	6.19	16.82	3.23	2.02	1.62	1.62	1.75	2.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	739.25	3.92	11.92	3.41	1.53	1.87	3.75	1.70	2.04	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	870.66	18.51	25.26	2.12	2.70	3.66	1.93	2.70	2.12	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1055.52	6.36	14.96	1.72	2.06	1.03	1.72	1.03	2.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	624.39	4.39	8.92	3.15	0.96	1.23	3.43	2.74	2.19	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	979.11	12.48	32.01	3.28	1.97	3.12	2.13	1.31	2.79	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	739.16	4.43	7.67	1.70	2.56	1.19	0.85	1.19	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	949.89	15.09	28.85	4.14	1.33	2.81	1.04	0.89	2.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	808.98	8.26	8.53	1.87	1.33	0.53	1.33	1.33	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	486.97	1.94	3.46	1.38	3.73	0.28	0.55	1.24	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	689.78	8.33	17.14	3.81	2.62	1.90	0.48	1.43	2.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	1039.15	9.88	13.30	4.64	5.44	1.41	1.21	1.41	2.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	567.02	3.77	3.86	2.07	3.20	0.57	0.38	0.28	1.70	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	595.31	21.31	26.55	2.10	3.84	4.54	0.70	1.05	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	449.69	5.14	7.56	0.91	4.23	0.60	1.21	0.91	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	764.43	4.16	6.85	3.43	4.41	1.59	0.00	0.24	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	843.04	1.31	2.77	6.99	7.86	0.29	0.29	0.44	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	484.31	2.43	9.13	1.83	4.87	1.22	0.00	0.00	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	753.50	2.41	5.43	1.81	3.32	0.30	0.00	0.00	2.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	468.89	6.79	9.05	3.39	4.75	0.68	0.68	0.00	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	479.26	5.09	13.48	4.19	3.29	0.90	0.30	0.30	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	663.81	1.18	3.42	2.48	5.67	0.35	0.24	0.24	0.94	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	444.82	5.98	1.49	4.70	5.34	1.92	0.85	0.43	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	408.06	8.41	8.41	4.21	5.41	1.80	1.20	2.40	1.80	0.00
Schwann Cells, donor1	11498-119F4	99.87	0.38	1.13	2.07	0.75	0.00	0.19	0.00	0.38	0.00
Schwann Cells, donor2	11578-120F3	500.15	3.40	23.82	0.00	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	331.25	3.94	8.76	2.63	0.88	0.88	0.88	0.66	0.22	0.00
Sebocyte, donor1	11220-116B5	302.92	0.00	1.10	4.38	0.00	0.00	0.00	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	177.39	0.46	3.22	2.76	0.00	0.46	0.00	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	103.47	0.21	0.41	2.68	0.41	0.21	0.41	0.21	0.41	0.00
Sertoli Cells, donor1	11255-116F4	533.42	3.31	4.97	0.00	0.00	0.00	3.31	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	192.06	2.82	11.30	0.00	2.82	0.00	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	222.32	0.70	1.06	1.76	1.58	0.09	0.00	0.09	0.62	0.00
Skeletal Muscle Cells, donor2	11358-117H8	18.79	0.00	0.00	0.00	2.89	0.00	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	136.27	0.00	0.84	0.84	0.00	0.00	0.00	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	829.14	2.98	6.60	3.93	0.94	0.79	0.79	0.63	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	773.99	2.97	6.99	1.78	0.74	0.74	0.74	0.00	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	1340.18	6.00	13.70	4.16	0.62	1.69	0.77	0.92	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	578.87	1.76	5.17	4.41	2.02	0.38	0.25	0.00	0.38	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	487.71	5.42	12.13	3.85	2.57	1.71	0.71	0.86	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	1104.21	6.45	11.51	4.86	0.99	1.79	1.39	0.60	0.69	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	310.64	1.26	1.43	1.01	1.69	0.34	0.25	0.08	0.42	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	57.18	0.00	0.00	0.72	0.72	0.00	0.00	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	65.77	0.41	0.83	0.41	0.28	0.00	0.14	0.00	0.41	0.00
Skin - palm, donor1	10286-104F7	136.99	40.29	8.06	0.00	0.00	0.00	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	305.03	2.74	5.05	2.74	0.43	1.01	1.30	1.30	0.72	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	726.29	4.09	7.36	17.18	0.82	0.00	2.45	4.09	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	333.92	1.69	2.47	2.73	0.39	0.13	1.95	0.91	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	418.41	0.83	2.50	5.70	0.28	0.14	0.42	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	273.16	2.95	5.06	5.06	0.28	0.14	1.27	0.56	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	1169.08	4.86	6.13	22.41	0.42	1.69	1.27	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	195.17	2.32	2.62	6.90	0.07	0.45	0.52	0.52	0.30	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	206.44	0.93	1.54	1.23	0.93	0.00	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	519.14	1.78	3.33	0.89	0.44	0.89	0.44	0.00	0.89	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	296.26	0.00	1.18	0.59	0.59	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	122.21	0.22	0.66	0.88	1.10	0.00	0.00	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	125.22	0.00	0.79	0.00	0.79	0.00	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	263.45	0.77	1.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	163.12	2.00	3.00	0.00	3.00	1.00	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	227.30	0.27	0.53	1.06	0.53	0.00	0.40	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	282.83	9.53	8.87	0.44	0.44	1.99	0.00	0.22	0.89	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	228.41	0.64	1.66	1.41	0.77	0.13	0.64	0.64	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	432.06	1.30	2.60	4.88	1.95	0.00	0.00	0.33	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	552.55	1.77	2.07	2.95	3.84	1.18	0.30	0.30	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	300.67	1.28	2.70	1.85	0.85	0.43	0.14	0.28	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	30.91	0.00	0.16	0.81	0.33	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	126.34	1.22	4.26	2.13	1.52	0.61	0.00	0.61	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	163.66	0.00	0.51	0.51	0.76	0.00	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	72.48	0.00	0.95	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	406.00	0.88	2.06	1.62	2.06	0.74	0.00	0.44	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	276.37	1.08	5.81	1.08	0.22	0.22	0.65	0.22	1.08	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	375.43	1.68	3.99	0.94	0.63	0.52	0.42	0.00	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	128.85	0.15	0.31	0.62	0.15	0.15	0.00	0.15	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	90.54	0.00	0.00	0.00	0.00	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	158.09	0.30	0.60	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	99.35	0.00	0.34	1.02	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	356.37	0.86	3.53	2.83	2.43	0.16	0.39	0.00	0.16	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	554.13	3.32	4.33	2.42	2.11	0.50	0.40	0.20	1.21	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	309.70	3.19	8.42	0.23	1.37	0.46	0.23	0.23	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	68.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	2006.28	14.31	12.45	1.85	0.53	1.85	1.32	1.85	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	591.49	0.40	2.26	0.27	0.27	0.53	0.40	0.00	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	266.72	3.63	10.89	0.25	0.38	1.88	0.63	0.00	0.63	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	161.33	0.76	1.52	1.01	3.04	0.00	0.51	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	456.39	1.06	1.81	1.36	0.75	0.30	0.30	0.45	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	81.77	0.00	0.75	0.75	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	49.10	1.29	0.00	0.00	2.58	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	166.50	0.47	0.47	0.00	1.40	0.00	0.00	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	201.95	1.51	4.54	0.50	0.00	0.50	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	164.22	0.63	1.57	0.63	0.00	0.00	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	33.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	1627.40	1.08	1.50	5.83	1.58	0.17	0.33	0.92	0.50	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	203.21	0.93	3.74	1.40	2.34	0.47	0.47	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	183.35	0.29	0.29	0.58	0.00	0.00	0.00	0.00	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	174.90	1.53	3.57	0.76	1.02	0.25	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	87.62	0.56	1.13	0.00	0.00	0.00	0.00	0.19	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	1004.76	1.96	5.73	2.52	0.70	0.70	0.56	0.28	0.84	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	526.02	0.25	1.09	2.51	1.68	0.50	0.17	0.08	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	35.71	0.48	0.00	0.00	0.48	0.00	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	172.00	0.49	0.24	0.49	0.49	0.00	0.24	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	622.85	2.43	2.43	0.44	1.55	0.44	0.66	0.22	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	590.13	1.17	4.39	0.29	0.29	0.29	0.29	0.88	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	193.97	2.92	4.47	0.97	2.33	0.78	0.39	0.39	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	377.37	7.14	12.69	0.53	1.59	2.38	0.53	0.53	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	577.26	3.72	17.48	0.74	1.12	2.60	0.37	0.37	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	448.09	6.11	10.06	1.80	2.87	1.44	0.72	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	330.18	1.99	3.12	1.14	1.14	1.42	0.85	0.57	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1107.56	11.82	31.12	4.73	1.18	5.51	0.79	1.18	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	254.97	3.56	6.86	0.51	1.02	1.27	1.02	0.25	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	161.32	4.39	3.19	0.00	2.00	1.20	0.00	0.40	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	221.96	2.51	6.69	1.25	2.93	0.84	0.84	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	220.01	1.38	3.67	0.46	2.29	1.38	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	478.20	3.20	5.89	1.51	2.19	0.84	0.00	0.00	1.01	0.00
Synoviocyte, donor2	11368-117I9	216.91	3.69	4.86	0.84	2.01	0.50	0.00	0.17	0.34	0.00
Synoviocyte, donor3	11440-118H9	206.65	4.92	4.69	0.22	0.67	0.67	0.00	0.00	0.89	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	207.61	0.00	0.36	1.07	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	71.35	0.00	0.00	1.98	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	110.68	0.69	0.00	0.93	0.93	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	319.00	0.86	1.43	1.94	0.07	0.29	0.14	0.00	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	85.43	0.00	0.77	1.55	0.00	0.39	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	44.09	0.00	0.00	2.29	0.00	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	5506.56	25.22	27.68	6.40	7.38	2.09	3.32	5.91	7.26	6.89
Urethra, donor2	10319-105A4	359.69	75.53	19.78	1.80	3.60	0.00	1.80	0.00	1.80	19.78
Urothelial Cells, donor1	11520-119H8	23.64	0.00	0.27	1.33	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	29.64	0.40	0.00	0.40	0.40	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	449.80	1.11	4.68	2.90	0.45	0.22	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	450.23	0.00	0.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	377.42	0.00	1.43	1.43	1.43	0.00	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	175.92	0.68	3.42	1.37	0.68	1.37	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	326.78	1.03	1.03	0.34	0.34	0.34	0.00	0.34	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	301.55	2.32	0.58	3.49	0.58	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	390.47	1.04	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	450.64	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	153.37	0.91	0.91	0.91	0.00	0.91	0.91	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	553.52	6.78	5.80	7.03	0.25	0.99	0.86	1.36	1.73	0.00
Wilms' tumor cell line:HFWT	10597-108E3	242.01	3.52	4.40	0.00	0.88	0.88	2.64	3.52	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	817.00	11.17	14.80	0.84	0.00	3.91	1.68	1.40	0.00	0.00
achilles tendon, donor2	10292-104G4	254.18	28.93	12.40	0.00	2.07	2.07	2.07	2.07	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	1743.90	48.70	53.29	5.61	0.25	8.41	2.29	1.27	0.25	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1679.09	8.13	16.02	3.71	1.86	2.09	0.46	1.39	0.93	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	1495.60	8.90	11.51	1.78	0.47	1.31	0.36	0.47	0.24	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	3311.35	58.23	71.84	10.34	0.82	13.33	2.99	1.63	0.82	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1382.65	20.80	52.56	2.81	0.28	6.46	1.97	2.81	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	862.42	2.75	2.11	1.69	1.27	0.42	0.42	0.00	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	562.12	19.05	14.43	1.63	0.54	2.45	2.18	0.54	0.00	3.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	894.94	17.63	25.12	2.64	1.76	4.41	2.20	1.76	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	653.78	15.93	22.46	1.23	0.82	5.72	3.27	1.23	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	614.29	12.43	19.03	1.16	1.16	3.49	3.49	0.78	1.94	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1123.87	18.58	51.34	1.29	0.00	6.44	3.13	3.50	0.18	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	553.87	3.90	3.90	0.00	0.00	3.90	0.00	0.00	3.90	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	1347.12	19.98	54.84	0.70	0.23	6.04	3.02	2.32	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1308.23	17.35	32.10	2.33	0.52	3.88	3.88	3.37	0.52	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1305.45	26.59	80.95	0.88	0.00	12.27	7.01	4.97	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	599.54	5.58	10.22	2.32	0.00	0.93	0.93	3.25	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	473.76	8.23	15.22	0.82	0.00	1.65	1.65	1.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	488.36	5.83	6.75	0.31	0.00	1.53	1.84	7.98	1.53	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1332.61	6.83	12.37	0.43	0.00	1.28	0.43	0.85	2.56	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1167.38	2.73	5.16	0.61	0.30	1.52	1.21	0.00	1.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	1433.16	1.68	7.70	1.44	0.00	0.72	0.24	0.96	1.44	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1093.65	20.49	35.42	2.45	0.67	4.23	3.12	4.01	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	2175.39	21.68	24.35	3.34	0.33	1.33	2.67	5.67	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	2752.00	22.30	24.16	3.72	0.00	1.86	31.59	40.88	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1536.02	19.21	31.26	1.51	0.75	4.90	2.64	0.75	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	874.01	7.41	11.34	0.87	0.87	0.44	1.31	0.44	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	569.84	13.12	3.75	1.87	0.00	0.00	1.87	11.25	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	636.32	7.30	6.12	0.24	0.00	2.59	1.65	1.18	1.65	0.24
adipose tissue, adult, pool1	10010-101C1	597.83	1.71	4.19	3.10	5.89	0.16	0.16	1.40	0.78	0.31
adipose, donor1	10184-103D4	1236.15	31.67	32.84	0.59	0.00	8.80	0.00	1.76	0.00	1.17
adipose, donor2	10185-103D5	189.38	7.30	5.27	3.24	0.00	1.62	1.22	0.81	0.00	1.22
adipose, donor3	10186-103D6	459.62	16.88	16.61	1.36	0.00	5.72	2.18	1.09	1.09	1.63
adipose, donor4	10187-103D7	806.08	28.60	41.60	5.20	0.00	9.53	4.33	0.87	0.87	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	1482.88	19.57	12.94	18.78	1.74	0.79	3.16	4.26	0.63	0.16
adrenal gland, adult, pool1	10081-102A9	349.22	14.55	3.64	0.00	0.00	3.64	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	653.02	3.34	5.47	1.73	0.13	0.93	0.40	0.13	0.00	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	888.25	13.58	18.22	4.29	0.71	4.29	2.86	1.43	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	935.05	2.09	4.87	6.49	0.00	2.32	0.46	0.46	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	602.16	0.34	2.37	16.23	0.68	0.68	0.68	0.34	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	814.28	6.48	9.43	2.06	0.00	2.95	0.59	0.59	0.00	0.88
amygdala - adult, donor10196	10167-103B5	1789.37	56.92	58.10	14.23	18.97	3.56	3.56	5.93	1.19	0.00
amygdala, adult, donor10252	10151-102I7	1335.63	99.36	31.23	26.36	51.91	5.88	3.85	7.10	3.24	9.53
amygdala, newborn, donor10223	10360-105E9	2224.52	39.06	45.19	10.01	6.78	4.20	4.52	10.33	5.49	8.39
anaplastic carcinoma cell line:8305C	10428-106D5	439.42	1.66	2.16	1.27	1.02	0.13	0.00	0.00	0.89	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	1104.44	26.03	31.99	1.76	0.00	6.40	5.29	4.63	0.88	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	477.67	20.38	13.36	8.35	0.00	2.67	1.34	2.00	0.33	3.34
aorta, adult, pool1	10052-101G7	449.54	27.46	6.28	1.18	2.55	1.37	1.57	1.18	0.20	14.91
appendix, adult	10189-103D9	535.60	4.27	6.21	2.72	2.33	0.39	1.55	1.94	0.78	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	1164.56	10.32	17.88	0.69	0.00	4.82	1.72	0.34	2.41	0.34
artery, adult	10190-103E1	399.45	1.36	6.79	0.00	4.08	0.00	1.36	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	682.47	2.03	2.75	4.64	0.43	0.87	0.87	0.14	1.45	0.00
b cell line:RPMI1788	10427-106D4	830.94	2.68	8.03	1.49	0.15	0.45	0.45	0.30	0.15	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	473.60	1.66	6.10	1.94	0.55	0.83	0.55	0.28	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	1905.25	5.46	11.01	5.56	0.20	0.69	0.60	0.69	4.27	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	446.57	2.68	4.69	2.85	0.17	0.17	0.84	0.50	1.34	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	232.08	5.03	4.47	0.00	0.00	0.56	0.56	1.68	0.00	0.00
bladder, adult, pool1	10011-101C2	696.39	4.56	3.80	0.98	5.32	0.22	1.20	1.41	0.87	1.20
blood, adult, pool1	10053-101G8	148.38	2.21	2.21	0.00	0.00	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	608.01	0.86	0.86	2.57	1.71	0.00	0.86	3.43	0.00	0.00
bone marrow, adult	10192-103E3	553.36	18.90	32.39	0.67	2.02	2.70	0.00	0.67	1.35	0.67
brain, adult, donor1	10084-102B3	259.34	39.98	1.03	9.23	11.28	1.03	0.00	1.03	1.03	3.08
brain, adult, pool1	10012-101C3	1023.60	9.02	10.13	20.60	24.28	1.78	1.00	1.00	1.00	0.22
brain, fetal, pool1	10085-102B4	307.21	16.03	2.67	21.37	16.03	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	890.66	16.19	26.10	4.63	0.00	2.64	7.93	13.21	1.32	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	1763.37	3.74	4.24	3.87	0.12	0.37	0.75	0.87	0.87	0.37
breast, adult, donor1	10080-102A8	1231.78	36.62	5.68	5.05	12.00	1.26	2.53	0.63	1.89	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	740.38	17.28	18.80	6.35	0.51	4.95	2.54	1.78	0.89	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	846.34	13.61	21.65	14.22	0.31	1.55	3.09	4.95	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	387.92	1.15	5.53	2.53	0.23	0.69	0.46	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	617.32	12.35	19.37	3.63	0.24	2.18	2.18	4.36	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	555.74	7.99	7.52	23.51	0.94	0.94	0.47	1.41	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	443.76	2.19	2.19	5.14	0.44	0.88	0.88	0.88	0.98	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	968.75	19.01	17.11	2.22	0.63	3.49	3.49	0.95	0.63	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	675.03	14.11	36.20	2.66	1.33	4.53	1.06	1.86	1.33	1.86
caudate nucleus - adult, donor10196	10177-103C6	1896.23	67.93	18.42	16.12	25.33	3.45	4.61	14.97	2.30	6.91
caudate nucleus, adult, donor10252	10164-103B2	1465.11	70.95	41.66	24.60	26.60	8.53	3.01	5.02	3.85	7.70
caudate nucleus, adult, donor10258	10379-105H1	958.99	19.87	41.26	19.87	9.93	6.88	4.58	3.82	3.06	3.82
caudate nucleus, newborn, donor10223	10354-105E3	3357.26	33.69	41.75	12.82	8.06	4.03	2.93	5.49	5.49	4.03
cerebellum - adult, donor10196	10173-103C2	1255.62	34.96	8.74	20.39	26.22	2.91	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	1885.08	50.82	33.09	27.33	53.38	4.48	3.63	2.56	1.28	6.19
cerebellum, adult, pool1	10083-102B2	420.14	13.11	18.97	11.04	7.24	3.45	2.76	0.69	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	1558.45	68.91	69.74	14.11	29.89	3.32	8.30	7.47	0.83	7.47
cerebral meninges, adult	10188-103D8	951.07	22.94	16.89	19.16	9.58	2.77	5.55	5.29	1.01	1.51
cerebrospinal fluid, donor2	10294-104G6	311.36	46.78	9.50	5.85	6.58	2.19	1.46	3.65	1.46	4.39
cervical cancer cell line:D98-AH2	10552-107I3	252.63	0.86	0.58	4.17	0.58	0.43	0.00	0.14	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	734.46	1.99	3.98	4.81	0.00	0.33	0.50	0.00	1.49	0.50
cervix, adult, pool1	10013-101C4	449.36	1.99	2.73	3.67	11.97	0.31	0.63	0.10	1.26	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	623.54	0.98	2.65	0.84	0.56	0.70	0.42	1.11	1.67	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	168.51	2.61	2.61	2.61	2.61	0.00	1.31	5.23	2.61	0.00
choriocarcinoma cell line:BeWo	10423-106C9	1241.89	5.22	11.56	3.48	0.37	1.62	0.99	0.12	0.99	0.00
choriocarcinoma cell line:SCH	10785-110H2	437.77	5.42	7.52	8.50	0.37	2.71	0.49	0.74	4.07	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	929.26	7.83	3.56	4.98	0.00	0.47	1.42	1.66	0.71	0.00
chorionic membrane cells, donor1	12238-129G6	649.33	1.14	6.55	2.56	0.28	1.71	1.42	0.85	0.85	0.28
chorionic membrane cells, donor2	12239-129G7	444.66	0.89	2.19	10.74	0.99	1.09	0.10	0.50	0.10	0.00
chorionic membrane cells, donor3	12240-129G8	525.86	5.49	11.54	6.59	0.55	2.20	1.10	1.65	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	950.22	15.15	39.38	2.02	0.00	6.06	1.01	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	960.69	12.10	10.95	0.77	0.38	3.27	2.31	1.15	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	729.23	6.97	4.43	0.42	0.00	0.63	1.48	1.06	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1280.15	8.73	15.15	3.08	0.00	1.28	2.31	2.57	0.51	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1400.23	11.85	15.00	1.69	0.00	1.45	3.63	1.94	0.97	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	1458.66	8.14	18.73	2.04	0.41	1.43	2.44	1.43	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	2211.95	19.14	26.21	1.18	0.29	3.24	2.36	2.36	0.88	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	1362.03	8.08	6.52	0.78	0.26	1.04	2.35	0.78	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	929.18	14.86	29.72	1.14	0.00	3.66	2.97	1.14	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	971.81	6.25	9.02	7.29	0.35	1.74	1.74	0.52	1.21	0.00
colon carcinoma cell line:CACO-2	10513-107D9	1053.04	2.93	4.76	0.92	0.00	0.55	0.55	0.73	2.01	0.00
colon carcinoma cell line:COLO-320	10420-106C6	832.38	1.90	3.80	3.42	3.42	0.00	0.38	0.00	1.90	0.00
colon, adult, donor1	10082-102B1	189.21	11.90	1.19	1.19	3.57	0.00	0.00	0.00	1.19	4.76
colon, adult, pool1	10014-101C5	419.25	2.59	0.82	3.29	4.23	0.71	0.71	0.47	0.59	0.47
colon, fetal, donor1	10070-101I7	237.93	4.94	8.65	0.00	2.47	0.62	0.00	1.24	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	261.26	0.00	0.00	0.00	13.75	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	275.40	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1658.94	4.25	7.22	2.12	0.42	1.70	0.85	0.42	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1202.32	3.62	4.23	1.36	0.91	0.75	0.75	0.60	0.00	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	1352.44	6.06	9.31	1.55	0.28	1.97	0.99	0.42	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	849.78	5.64	2.32	48.87	89.11	0.33	0.22	0.55	1.00	4.09
cruciate ligament, donor2	10295-104G7	280.42	29.99	4.86	0.00	5.67	0.81	0.00	1.62	1.62	0.81
diaphragm, fetal, donor1	10069-101I6	265.65	4.82	2.41	0.80	1.61	0.80	0.00	1.61	0.80	3.21
diencephalon, adult	10193-103E4	996.91	26.88	28.80	19.92	31.68	3.36	6.24	3.60	2.88	5.52
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	559.33	17.91	35.36	1.84	0.00	3.21	1.15	0.46	0.00	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	963.96	2.31	2.56	18.46	1.03	0.00	0.77	0.51	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	842.77	5.30	9.87	7.70	1.20	0.48	0.24	0.48	0.48	0.96
ductus deferens, adult	10196-103E7	637.88	17.44	8.47	1.99	1.50	2.99	1.00	2.49	1.99	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	361.50	12.96	10.08	2.88	0.00	0.00	1.44	1.44	0.00	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	469.34	19.86	21.33	1.47	1.47	2.21	2.94	0.74	0.74	2.94
dura mater, adult, donor1	10041-101F5	315.90	1.82	1.57	1.90	3.39	0.08	0.25	0.58	0.33	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	719.29	3.78	1.55	5.11	0.44	0.22	0.44	0.00	16.43	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	1938.33	5.59	8.17	7.31	0.43	1.58	2.15	1.00	2.15	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	407.58	2.47	10.48	3.08	0.00	0.62	1.85	6.78	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	687.46	7.27	13.32	7.87	1.51	1.82	3.33	3.94	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	498.01	5.25	5.56	3.70	0.31	0.31	1.85	1.54	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	566.10	2.63	7.88	0.00	0.00	0.00	2.63	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	762.91	3.02	4.69	12.40	0.67	0.34	1.68	1.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	501.48	7.97	15.95	9.24	2.17	1.45	0.72	0.72	0.91	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	981.92	16.08	32.32	9.97	0.16	4.50	2.57	0.48	1.77	0.00
epidermoid carcinoma cell line:A431	10426-106D3	1476.30	3.33	4.67	7.89	0.67	0.56	1.00	1.33	0.22	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	3034.06	7.59	22.00	8.36	0.44	1.98	1.43	2.53	2.64	0.33
epididymis, adult	10197-103E8	357.92	6.07	5.86	3.56	1.88	0.42	0.84	1.88	0.63	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	1000.24	15.26	21.29	16.14	2.66	1.77	1.06	1.60	0.71	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	322.85	2.75	3.15	3.93	0.39	1.57	1.97	2.36	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1417.30	15.86	33.29	2.88	0.00	3.67	1.83	0.79	5.24	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	824.56	9.05	12.50	1.87	0.10	2.46	0.89	0.59	3.94	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	1411.80	17.14	28.79	2.58	0.22	4.93	2.13	0.90	5.94	0.00
esophagus, adult, pool1	10015-101C6	515.92	2.23	2.55	1.49	3.50	0.42	0.42	0.32	0.74	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1489.68	4.51	4.01	16.91	0.50	0.38	0.50	1.50	0.75	0.00
eye - muscle inferior rectus, donor1	10272-104E2	268.02	142.46	9.66	0.00	4.83	0.00	0.00	9.66	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	317.73	42.08	12.63	0.00	6.31	6.31	4.21	10.52	0.00	0.00
eye - muscle medial, donor2	10299-104H2	260.44	63.99	5.95	0.00	1.49	1.49	4.46	14.88	5.95	0.00
eye - muscle superior, donor2	10297-104G9	303.82	49.30	14.90	3.44	3.44	4.59	1.15	1.15	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	268.16	20.40	7.29	4.37	0.00	0.00	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	825.75	10.68	20.34	5.59	4.58	4.32	1.53	1.02	2.80	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	606.24	7.69	7.31	0.51	0.13	2.44	1.28	1.54	1.41	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	970.10	10.21	17.33	1.19	0.24	2.85	4.75	5.22	0.95	0.24
frontal lobe, adult, pool1	10040-101F4	1426.69	7.98	8.73	32.09	28.05	1.03	0.56	1.31	1.50	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	1292.87	48.04	40.53	10.21	0.90	5.10	3.00	3.90	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	997.48	1.10	2.65	4.30	0.73	0.00	0.73	0.46	0.73	0.00
gall bladder, adult	10198-103E9	274.75	4.83	3.62	0.97	2.17	0.72	0.97	0.97	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	544.37	0.00	3.22	0.54	0.54	0.54	0.54	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	459.39	1.12	1.87	0.37	1.87	0.37	0.37	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	566.06	14.57	21.97	3.59	0.21	2.11	1.06	0.63	0.63	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	569.03	6.96	16.25	5.03	0.58	2.32	1.55	2.13	0.39	0.19
gastric cancer cell line:AZ521	10549-107H9	898.31	1.48	3.12	5.25	0.82	0.33	0.33	0.33	1.31	0.16
gastric cancer cell line:GSS	10560-108A2	282.80	7.32	10.98	0.00	0.00	2.75	0.00	0.00	0.00	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	576.17	12.11	25.36	3.20	0.46	3.20	0.91	1.14	0.23	5.25
giant cell carcinoma cell line:LU65	10487-107B1	385.18	2.52	3.90	4.47	0.00	0.11	0.23	0.11	1.26	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	1587.84	4.34	6.44	1.82	0.28	0.84	0.14	0.98	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	1341.62	13.47	13.22	8.98	0.50	2.49	5.24	6.98	1.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	818.77	2.64	5.49	0.21	0.32	0.63	1.37	1.69	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	833.22	4.92	10.95	0.56	0.14	0.84	1.69	2.53	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	425.27	3.53	3.53	1.88	0.33	0.22	0.11	0.33	0.11	0.00
glioma cell line:GI-1	10413-106B8	767.34	3.22	4.98	2.93	3.22	0.59	0.59	0.59	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	972.37	53.21	16.04	16.04	32.07	0.00	1.46	3.64	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	2138.51	109.60	42.72	75.67	136.94	4.64	3.42	6.59	1.71	13.43
globus pallidus, adult, donor10258	10367-105F7	881.77	30.12	24.65	21.91	17.80	1.37	4.11	6.85	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	1244.89	11.72	15.99	12.79	18.12	1.07	1.60	3.20	2.13	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	247.16	0.00	0.00	2.45	7.34	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	185.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	67.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	353.91	6.72	6.40	3.52	2.88	0.64	1.28	1.28	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	1323.17	11.94	49.58	3.67	1.38	5.97	0.00	1.38	4.13	0.00
hIPS +CCl2, biol_rep2	14384-156C1	1343.89	11.43	37.50	1.83	1.37	2.29	0.91	1.37	3.20	0.46
hIPS +CCl2, biol_rep3	14385-156C2	1433.75	16.10	61.83	3.22	0.00	5.15	1.93	0.64	2.58	0.00
hIPS, biol_rep1	14380-156B6	1251.88	12.94	7.19	2.87	1.44	1.44	0.00	0.00	2.87	2.87
hIPS, biol_rep2	14381-156B7	1101.50	13.72	56.93	5.49	0.69	2.74	2.74	2.74	2.74	0.69
hIPS, biol_rep3	14382-156B8	1344.02	30.90	69.52	6.62	11.03	5.52	7.72	12.14	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	577.85	13.79	16.09	1.44	0.00	1.72	2.30	2.59	0.00	0.86
heart - mitral valve, adult	10205-103F7	1361.20	23.62	14.05	2.99	5.38	1.79	4.78	5.98	1.79	5.08
heart - pulmonic valve, adult	10206-103F8	476.41	14.38	14.12	1.57	3.92	1.31	1.31	3.66	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	2260.62	129.06	22.48	3.33	2.50	2.50	2.50	6.66	1.67	121.57
heart, adult, diseased post-infarction, donor1	10050-101G5	273.44	8.77	7.96	3.26	0.82	1.02	0.41	1.02	0.41	0.61
heart, adult, diseased, donor1	10051-101G6	144.36	5.54	0.43	0.43	0.85	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	484.79	3.22	0.69	1.38	1.61	0.00	0.00	1.15	4.37	0.46
heart, fetal, pool1	10046-101G1	818.98	6.67	3.80	1.54	5.03	0.41	0.82	1.23	6.98	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	378.56	3.09	0.93	1.54	0.62	0.31	0.62	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	891.88	16.65	13.08	4.76	0.00	2.38	2.38	16.65	5.95	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	1647.16	15.69	28.62	2.10	0.00	3.20	1.88	1.22	2.87	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	1823.04	16.14	32.65	1.70	0.12	6.43	2.18	1.21	2.43	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	1872.92	16.98	24.66	2.83	0.00	4.35	1.92	1.01	2.83	0.10
hepatoma cell line:Li-7	10484-107A7	560.08	2.34	4.78	0.67	0.11	0.56	0.67	0.33	1.67	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	918.98	7.74	12.76	2.61	0.10	3.22	0.90	0.70	0.40	0.00
hippocampus - adult, donor10196	10169-103B7	1624.84	155.20	59.62	10.41	18.93	9.46	2.84	15.14	4.73	1.89
hippocampus, adult, donor10252	10153-102I9	1466.46	143.48	39.80	33.88	68.58	9.59	3.67	6.33	2.86	10.00
hippocampus, adult, donor10258	10374-105G5	1221.47	41.33	79.17	8.96	18.42	3.49	1.99	10.95	1.00	7.47
hippocampus, newborn, donor10223	10363-105F3	1225.92	20.80	9.52	10.22	12.69	0.35	2.47	2.11	3.88	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1828.59	11.60	59.20	1.22	0.00	4.27	3.05	1.83	0.61	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	956.84	11.39	21.99	3.53	0.39	4.52	2.36	1.18	1.37	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1168.43	7.11	20.57	5.84	0.00	4.06	2.79	0.51	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	390.76	4.51	6.20	2.26	0.00	2.26	0.56	0.00	1.69	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	409.78	9.81	22.46	1.81	0.26	1.55	2.58	1.03	0.26	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	568.28	3.42	4.93	1.14	0.38	0.38	0.76	0.76	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	529.90	4.67	7.30	0.88	2.34	0.88	0.88	0.29	1.17	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	472.65	8.19	10.56	1.94	1.72	1.29	1.72	1.72	0.86	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	555.12	3.34	2.50	2.09	1.67	0.83	2.09	0.42	2.09	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	939.36	2.84	4.97	1.89	1.66	0.95	0.95	0.71	2.37	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	724.67	8.36	11.41	1.93	1.61	2.89	2.41	1.13	1.77	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	808.64	2.02	4.71	3.37	2.69	0.00	1.35	0.67	2.69	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1106.97	13.46	23.79	2.35	0.31	4.85	3.60	1.72	1.72	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	1041.54	19.65	66.82	1.47	0.00	5.90	3.44	2.95	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1694.89	10.47	46.26	2.62	0.00	4.36	1.75	1.75	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	468.88	4.58	6.30	3.44	0.19	1.72	0.57	1.15	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	447.41	4.36	10.03	1.31	0.44	1.74	1.31	0.44	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	570.73	8.00	12.99	3.50	0.50	2.00	0.50	0.50	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	331.76	5.84	7.16	3.96	1.13	1.13	2.26	0.94	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	304.21	6.82	4.09	2.73	1.82	0.91	0.91	0.91	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	332.34	5.95	3.45	1.25	0.63	0.31	0.94	0.94	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	517.50	9.47	9.63	3.92	0.33	1.14	1.14	0.49	0.65	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	516.17	6.97	9.00	3.19	0.29	1.16	0.29	0.58	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	452.27	10.76	11.36	3.29	0.30	2.09	0.90	0.60	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1067.09	11.64	28.82	3.88	0.00	4.62	4.25	1.66	1.11	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	973.96	8.27	17.12	3.71	0.29	3.42	2.85	0.86	1.71	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1607.52	8.17	24.91	4.49	0.00	6.53	2.04	0.82	4.49	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	524.60	7.04	20.77	3.87	1.06	0.70	0.70	0.35	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	476.69	6.65	8.87	3.48	1.27	0.95	2.22	0.63	1.58	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	521.11	5.14	6.05	3.33	1.21	0.30	0.61	0.30	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	376.47	4.14	5.17	5.69	1.03	0.52	0.00	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	421.75	5.31	5.31	1.99	0.66	1.33	1.33	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	410.97	3.33	6.41	3.08	0.77	0.77	0.77	0.26	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	621.22	4.35	15.08	1.79	1.02	1.02	1.79	0.51	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	499.01	6.82	4.54	4.54	0.76	1.51	2.27	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	592.47	7.39	7.06	3.70	0.00	0.67	1.34	0.67	1.68	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1137.25	9.90	22.94	4.35	0.00	3.14	2.42	1.93	0.48	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1294.19	10.70	31.20	5.35	0.00	4.01	1.34	0.89	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1159.03	8.78	22.93	4.39	0.00	3.90	3.41	2.44	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	507.02	4.58	7.95	3.36	1.53	0.31	1.22	1.22	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	5579.31	35.79	146.40	6.51	0.00	3.25	3.25	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	745.61	2.65	7.28	4.63	0.00	0.66	0.33	0.00	0.33	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	465.20	7.66	6.02	6.02	2.74	1.64	1.09	1.09	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	415.08	3.98	5.43	5.07	1.09	0.00	1.09	0.00	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	413.17	4.98	2.85	3.20	1.42	0.36	1.07	1.42	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	497.64	5.97	15.51	2.39	0.00	1.19	2.39	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	965.45	3.93	5.69	2.98	1.22	0.41	0.14	0.27	1.08	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	520.74	3.77	5.39	3.77	1.35	0.81	1.08	0.27	0.54	0.54
immature langerhans cells, donor1	11904-125F5	1094.74	2.66	8.72	1.94	0.00	0.97	0.24	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	586.18	5.54	4.75	2.38	0.00	0.79	0.00	1.58	0.00	1.58
insula, adult, pool1	10039-101F3	663.38	6.53	2.46	27.92	23.75	0.09	0.66	0.76	1.32	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	302.71	5.20	7.48	1.95	0.00	0.98	0.65	0.98	0.33	0.00
kidney, adult, pool1	10017-101C8	911.26	4.91	7.01	6.81	1.50	0.60	1.30	1.10	1.80	0.20
kidney, fetal, pool1	10045-101F9	421.66	3.32	0.28	5.87	3.75	0.21	0.35	0.00	0.35	0.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	1221.81	1.56	2.27	2.13	0.14	0.43	0.71	0.85	1.56	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	355.14	1.94	6.08	0.55	0.55	0.55	0.41	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	439.12	3.30	2.02	5.14	0.18	0.55	0.55	1.10	0.92	0.00
left atrium, adult, donor1	10079-102A7	260.44	14.17	11.99	0.00	0.00	0.54	1.09	2.18	1.63	0.00
left ventricle, adult, donor1	10078-102A6	308.45	16.69	7.08	0.51	0.51	0.51	1.52	0.51	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	679.10	5.75	3.83	18.61	1.09	1.37	1.37	2.46	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	251.47	2.51	5.39	1.08	0.00	0.72	1.08	0.00	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	303.26	0.54	9.24	0.54	1.63	0.54	1.09	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	368.84	3.89	11.17	0.00	0.49	0.97	0.49	0.00	0.49	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	311.12	0.00	0.00	0.00	6.35	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	261.39	3.14	5.23	1.05	2.09	0.00	1.05	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	906.33	13.81	17.35	6.61	2.36	3.66	1.53	0.94	0.12	0.47
liposarcoma cell line:KMLS-1	10782-110G8	1162.52	14.37	13.75	1.09	0.94	1.72	2.19	1.25	1.87	0.78
liposarcoma cell line:SW 872	10726-110A6	654.76	6.94	5.97	6.70	0.73	0.73	1.10	1.71	1.83	0.12
liver, adult, pool1	10018-101C9	561.38	3.08	3.08	0.81	0.16	0.16	1.13	1.13	1.62	0.16
liver, fetal, pool1	10086-102B5	594.53	23.52	0.00	0.00	0.94	0.94	0.00	0.94	0.00	5.64
locus coeruleus - adult, donor10196	10182-103D2	1351.65	98.14	34.27	23.33	33.98	6.12	7.44	10.94	2.04	3.35
locus coeruleus, adult, donor10252	10165-103B3	1915.64	98.00	40.42	35.25	68.65	8.30	3.32	5.54	2.77	21.78
locus coeruleus, adult, donor10258	10375-105G6	986.64	16.36	22.57	11.29	25.11	4.80	4.51	6.49	1.13	2.26
locus coeruleus, newborn, donor10223	10362-105F2	3401.96	34.91	54.26	5.05	6.31	5.89	5.89	9.25	2.52	3.36
lung adenocarcinoma cell line:A549	10499-107C4	367.71	0.97	0.97	4.43	0.28	0.42	0.00	0.42	0.55	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	3362.23	4.14	6.20	21.37	0.69	0.69	0.69	4.83	2.07	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	287.23	1.85	1.98	1.45	0.00	1.05	0.79	0.40	0.26	0.00
lung, adult, pool1	10019-101D1	788.50	5.08	3.66	0.95	2.36	0.59	0.83	2.01	0.35	3.54
lung, fetal, donor1	10068-101I5	1952.19	7.99	1.43	2.28	12.84	0.00	1.71	2.28	2.57	1.71
lung, right lower lobe, adult, donor1	10075-102A3	408.27	19.25	11.91	0.92	0.92	3.67	2.29	1.37	0.46	3.21
lymph node, adult, donor1	10077-102A5	192.19	5.21	6.15	0.47	0.00	1.42	0.47	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	487.67	6.79	7.89	1.32	0.00	2.41	0.66	1.10	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	1340.23	6.64	6.49	7.09	0.00	1.51	2.87	1.06	0.30	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	425.60	1.70	1.70	2.55	0.00	0.00	0.00	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	1384.36	2.66	1.78	4.00	10.21	1.33	1.33	1.78	5.33	0.00
mature adipocyte, donor2	12232-129F9	1261.15	0.83	1.66	2.08	6.64	0.00	0.62	0.83	2.91	0.42
mature adipocyte, donor3	12233-129G1	1258.80	1.90	0.95	2.84	4.27	0.47	0.47	0.95	4.98	0.00
mature adipocyte, donor4	12234-129G2	1893.59	1.32	2.90	2.90	6.05	0.79	1.05	1.58	5.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	740.75	2.38	1.19	5.48	0.71	0.48	0.00	0.48	2.14	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	1930.06	84.60	65.43	12.41	20.30	9.02	3.38	7.90	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	1376.54	73.93	37.15	32.92	56.64	6.07	2.76	5.52	2.39	3.49
medial frontal gyrus, adult, donor10258	10368-105F8	927.33	35.58	68.62	9.85	12.07	10.48	3.18	5.08	1.59	2.22
medial frontal gyrus, newborn, donor10223	10352-105E1	5888.52	91.27	162.49	16.21	5.12	20.47	16.63	19.62	1.28	15.35
medial temporal gyrus - adult, donor10196	10183-103D3	1540.86	49.61	120.66	22.28	24.30	7.26	6.75	5.57	2.53	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	1445.46	104.20	38.20	38.20	68.12	7.85	3.61	6.79	1.91	5.52
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	620.26	32.75	48.16	7.71	5.78	1.93	5.78	13.48	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28003.90	473.67	1119.58	43.06	71.77	86.12	71.77	186.60	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	2270.61	40.20	44.51	16.87	4.67	5.03	2.87	4.67	1.44	3.23
medulla oblongata - adult, donor10196	10174-103C3	1353.12	96.70	22.07	11.03	20.77	2.60	1.95	3.89	3.89	5.84
medulla oblongata, adult, donor10252	10155-103A2	2395.28	62.23	36.38	37.00	71.05	4.95	2.01	3.25	3.56	19.66
medulla oblongata, adult, pool1	10038-101F2	701.83	9.47	2.04	20.49	34.28	0.24	0.41	0.82	2.04	1.88
medulla oblongata, newborn, donor10223	10361-105F1	2194.88	22.57	33.33	9.37	22.91	5.55	3.12	4.86	4.86	1.39
medulloblastoma cell line:D283 Med	10838-111E1	975.98	13.73	30.78	7.97	0.89	3.10	1.77	1.33	0.66	2.21
medulloblastoma cell line:ONS-76	10759-110E3	1222.24	15.53	15.28	3.30	0.12	3.06	3.67	4.16	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	1398.22	4.46	6.04	3.16	0.57	1.15	0.14	1.44	1.58	0.00
melanoma cell line:G-361	10465-106H6	589.07	11.13	14.39	2.17	0.54	1.90	1.36	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	537.83	5.07	16.28	2.17	0.00	1.81	2.17	0.36	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	1425.71	19.39	35.25	7.93	0.88	3.52	7.05	6.17	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	1268.38	4.93	15.81	10.89	0.52	3.63	3.11	0.52	3.11	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	448.33	2.30	5.52	1.38	0.31	1.23	0.31	0.46	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	246.31	1.27	3.64	0.73	0.73	0.00	0.00	0.00	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	374.35	2.07	4.56	1.24	0.83	0.41	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	397.40	2.39	5.62	1.12	3.37	0.84	0.00	0.14	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	269.21	1.35	2.89	1.35	2.12	0.39	0.19	0.19	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	285.96	3.47	5.55	1.39	1.39	1.39	0.69	0.00	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	267.75	1.03	1.89	1.37	0.69	0.86	0.00	0.17	0.51	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	275.69	1.96	2.53	0.69	1.61	0.46	0.12	0.23	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	369.13	0.93	3.32	1.59	0.40	0.53	0.00	0.27	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	627.53	4.05	8.91	1.35	0.27	1.22	0.41	0.14	0.41	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	615.86	2.28	8.54	1.28	0.28	1.42	0.14	0.28	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	274.02	1.65	4.28	0.99	0.99	0.33	0.66	0.66	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	377.76	1.52	2.91	0.55	0.42	0.42	0.14	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	465.33	5.93	12.57	1.40	1.05	1.05	1.75	1.05	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	343.41	2.45	3.27	1.02	0.82	0.82	0.00	0.82	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	209.56	4.31	8.63	0.36	1.08	1.08	0.36	0.00	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	233.49	1.14	2.90	0.10	0.62	0.52	0.10	0.10	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	287.27	4.79	10.49	1.82	0.46	0.91	0.46	0.00	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	1276.71	8.39	15.94	0.42	0.00	2.10	0.42	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	348.79	1.64	4.78	0.45	0.30	0.90	0.15	0.15	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	321.76	2.19	3.33	0.70	0.53	1.14	0.09	0.18	0.79	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	258.82	1.10	3.68	0.37	3.31	0.00	0.37	0.74	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	280.15	4.58	10.02	0.57	0.57	2.00	0.29	0.29	0.57	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	687.94	10.10	37.47	2.95	2.95	2.53	1.68	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	165.77	0.91	2.28	0.91	0.46	0.00	0.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	254.51	1.79	2.81	0.51	0.00	1.02	0.00	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	238.46	1.57	2.62	0.26	0.26	0.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	193.48	0.92	2.46	0.92	0.00	0.00	0.62	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	234.41	1.88	2.82	0.00	0.47	0.24	0.24	0.47	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	242.00	0.34	3.05	0.68	0.34	0.00	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	227.92	3.14	3.14	1.57	0.00	0.79	0.00	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	253.47	0.93	4.17	0.93	0.46	0.46	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	241.52	0.00	0.00	0.00	0.00	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	333.12	2.60	2.88	0.58	0.58	0.29	0.00	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	238.72	0.89	2.90	0.67	0.45	0.00	0.00	0.22	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	230.98	0.24	2.88	1.20	1.44	0.24	0.00	0.24	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	357.86	0.00	8.07	0.73	0.00	0.73	0.73	0.73	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	216.16	0.34	1.68	0.00	0.67	0.34	0.67	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	241.94	1.64	2.05	0.00	0.00	1.23	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	247.00	0.43	3.44	0.43	0.43	0.43	0.43	0.00	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	120.31	2.73	0.00	0.00	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	180.77	5.16	15.49	0.00	0.00	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	209.81	3.90	5.52	0.65	1.30	0.65	0.65	0.32	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	219.70	1.45	8.73	1.45	0.00	0.00	0.00	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	186.04	5.33	6.93	0.53	0.53	0.53	0.00	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	169.28	1.64	7.36	0.82	1.64	0.00	0.00	1.64	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	164.82	3.11	7.00	1.17	0.78	1.55	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	214.07	0.00	12.59	2.10	0.00	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	154.98	3.97	3.97	1.99	0.99	0.00	0.99	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	166.85	0.00	0.00	0.00	0.00	0.00	9.53	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	199.83	3.56	4.15	1.19	0.00	1.19	1.19	1.78	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	180.33	6.09	4.87	0.00	0.00	1.22	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	162.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	188.11	3.17	5.07	0.63	0.63	1.27	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	125.55	3.10	3.79	0.69	1.72	1.38	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	139.70	0.00	2.15	2.15	0.00	0.00	4.30	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	83.83	3.99	3.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	134.31	6.89	3.44	0.00	0.00	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	99.42	0.41	5.30	1.22	1.63	0.41	0.81	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	112.81	3.97	6.36	1.59	2.38	0.00	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	109.65	1.18	5.31	1.18	2.95	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	131.54	1.56	2.81	0.62	1.87	0.62	0.31	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	173.77	2.67	5.35	0.00	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	255.46	2.37	10.64	1.18	2.37	0.00	0.00	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	354.38	5.14	51.36	0.00	0.00	7.70	5.14	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	315.29	8.26	13.77	1.38	6.20	2.07	1.38	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	541.81	4.45	24.74	0.00	0.99	3.96	1.48	0.49	2.47	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	405.99	4.49	33.65	1.12	0.00	3.36	1.12	0.00	3.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	501.85	10.18	34.98	0.64	0.00	6.36	2.54	1.27	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	397.74	5.64	8.46	0.40	0.40	1.21	1.61	0.00	3.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	366.34	13.08	17.44	2.18	2.18	2.18	6.54	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	239.47	2.53	8.87	0.00	1.27	0.00	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	182.07	1.21	3.64	0.61	1.82	0.61	0.61	0.00	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	284.70	4.52	40.67	0.00	4.52	9.04	0.00	4.52	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	186.98	5.77	13.18	0.00	1.65	1.65	2.47	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	276.61	0.40	1.19	0.20	1.19	0.60	0.00	0.00	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	203.78	2.27	3.57	0.65	2.27	0.65	0.00	0.32	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	243.45	6.11	16.30	1.02	2.04	7.13	0.00	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	454.17	0.00	0.77	3.09	3.87	0.00	1.55	0.77	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	398.07	0.94	2.83	3.07	0.94	0.24	0.47	0.47	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	447.13	0.93	2.78	2.09	0.00	0.70	0.23	0.70	0.46	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	1311.99	25.64	102.57	12.82	0.00	8.55	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1384.15	11.71	20.04	3.60	0.62	2.57	2.98	1.13	0.72	0.00
mesothelioma cell line:Mero-25	10850-111F4	186.10	0.68	7.49	0.68	0.00	0.45	0.45	0.45	1.59	0.00
mesothelioma cell line:Mero-41	10851-111F5	546.40	5.87	17.36	4.40	0.00	0.73	1.22	0.98	1.22	0.00
mesothelioma cell line:Mero-48a	10852-111F6	736.04	10.19	24.80	4.87	0.00	2.44	1.99	2.21	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	376.60	7.10	22.08	3.15	0.00	1.31	1.58	0.26	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	828.80	15.66	28.26	8.68	1.53	2.55	1.36	1.19	0.68	0.17
mesothelioma cell line:Mero-84	10855-111F9	589.22	5.81	9.86	1.01	0.00	0.76	1.01	0.51	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	572.47	5.59	11.59	4.14	0.83	2.28	0.41	0.41	1.66	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	1250.31	14.41	39.42	3.48	0.66	4.14	1.82	1.99	1.16	0.00
mesothelioma cell line:NCI-H226	10846-111E9	1175.36	17.56	38.91	7.60	0.54	3.26	1.81	1.63	1.63	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	388.79	5.12	8.71	0.85	0.34	1.54	0.34	0.34	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	365.41	5.09	12.21	1.02	0.25	1.02	1.02	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	313.48	2.94	9.79	0.98	0.00	0.98	0.33	0.33	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	561.41	10.03	17.34	1.90	0.00	1.90	0.81	1.63	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	1337.12	3.65	7.68	3.84	0.38	2.11	1.34	0.77	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	784.96	1.47	1.95	3.05	1.22	0.24	0.61	0.37	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	733.54	1.44	3.41	2.87	0.72	0.54	0.18	0.18	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	363.70	7.84	14.69	3.59	0.00	3.92	0.98	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	911.54	15.68	16.32	3.18	0.00	3.60	2.12	0.21	1.48	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	842.88	11.98	7.14	4.84	0.00	0.92	3.46	2.53	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	393.90	4.00	5.52	1.14	0.19	1.52	0.76	0.57	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1088.61	4.80	7.21	1.66	1.48	1.48	1.11	1.48	0.37	0.18
myeloma cell line:PCM6	10474-106I6	265.27	2.77	1.38	1.19	0.00	0.59	0.20	0.40	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	662.52	8.62	12.68	0.51	0.51	2.03	5.07	9.13	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	381.69	2.75	6.86	0.59	0.98	0.20	1.37	0.78	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	139.17	0.00	0.33	3.90	0.00	0.00	0.00	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	169.95	0.15	0.44	2.35	0.07	0.07	0.15	0.00	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	108.74	1.66	2.21	3.86	0.00	0.00	0.00	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	1080.14	2.53	3.45	0.92	2.07	0.92	0.46	0.92	1.61	0.46
neuroblastoma cell line:NB-1	10539-107G8	1543.27	3.93	6.74	1.31	1.68	0.75	1.87	0.94	1.31	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	108.61	1.27	3.16	0.63	0.63	0.21	0.42	0.00	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	750.99	8.94	13.42	2.98	6.15	2.61	0.37	0.56	0.19	5.22
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	266.40	5.22	13.76	0.24	1.66	0.71	0.71	0.47	0.00	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	658.23	8.39	13.46	1.58	0.48	1.74	0.79	0.63	0.63	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	472.36	6.44	9.86	7.25	1.01	4.63	0.40	0.20	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	477.46	12.08	5.72	3.18	1.27	0.64	1.91	3.81	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	323.13	1.86	1.06	4.26	0.27	0.00	1.06	0.53	1.06	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2617.81	11.84	19.62	2.37	0.85	2.37	1.01	1.18	0.00	5.41
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	1119.91	1.60	2.40	0.80	0.00	0.00	1.60	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	273.80	2.89	1.28	1.92	0.64	0.32	0.96	0.00	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	283.26	3.15	5.78	0.53	0.53	0.53	0.26	0.26	1.31	0.00
nucleus accumbens, adult, pool1	10037-101F1	1016.23	5.81	5.16	28.03	27.00	0.94	0.56	0.94	1.50	0.75
occipital cortex - adult, donor10196	10172-103C1	1677.15	70.05	26.78	16.48	24.72	2.06	0.00	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	1521.62	121.57	35.42	51.53	88.02	7.51	3.22	8.32	3.49	10.47
occipital cortex, newborn, donor10223	10355-105E4	2153.45	24.02	31.30	16.74	6.19	1.46	2.55	6.55	2.55	3.28
occipital lobe, adult, donor1	10076-102A4	620.31	35.69	6.56	17.32	19.16	4.99	4.20	3.15	0.79	2.36
occipital lobe, fetal, donor1	10073-102A1	597.74	39.91	18.45	34.33	44.20	8.15	3.43	2.15	0.86	0.43
occipital pole, adult, pool1	10036-101E9	225.80	0.24	0.32	12.14	15.14	0.00	0.08	0.08	0.47	0.08
olfactory region, adult	10195-103E6	799.36	66.49	51.20	15.86	28.66	8.60	4.39	5.54	0.57	2.87
optic nerve, donor1	10277-104E7	572.30	14.01	10.01	60.03	84.04	4.00	2.00	8.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	802.14	2.16	5.70	25.97	0.46	0.91	0.34	0.23	1.94	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	2624.63	4.81	9.07	19.51	0.69	1.10	1.10	0.96	0.27	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	651.90	9.14	32.34	5.76	0.17	3.39	2.88	1.02	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	661.40	5.20	13.75	6.01	0.35	2.43	0.81	1.16	0.35	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	260.45	0.59	2.65	1.18	1.76	0.59	0.88	0.88	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1348.25	0.93	0.00	9.34	5.61	0.00	0.93	1.87	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	567.68	2.54	3.82	4.67	3.18	0.42	0.21	0.42	0.85	0.00
ovary, adult, pool1	10020-101D2	635.05	1.57	2.36	2.10	5.77	0.52	0.87	0.96	0.17	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	688.00	6.78	6.23	2.93	0.18	0.73	3.12	2.38	0.73	0.18
pancreas, adult, donor1	10049-101G4	364.97	2.82	0.94	0.94	0.00	1.88	0.00	0.00	1.88	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	644.61	9.78	10.34	2.52	0.00	1.68	0.56	1.68	4.19	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	246.67	13.97	25.72	1.70	0.68	4.26	3.24	1.02	1.02	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	1371.35	4.80	5.80	4.47	0.17	0.50	0.99	1.16	1.16	0.00
paracentral gyrus, adult, pool1	10035-101E8	835.23	4.12	4.21	24.44	26.36	0.64	0.27	1.01	0.64	0.64
parietal cortex, adult, donor10258	10373-105G4	1106.15	33.76	49.18	14.68	13.21	7.34	4.40	11.74	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	1248.02	84.64	47.96	16.93	29.15	7.52	3.76	11.29	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	1416.63	88.93	45.04	35.91	51.59	5.42	2.00	5.13	2.57	10.55
parietal lobe, adult, pool1	10034-101E7	687.07	4.14	2.29	25.03	31.55	0.18	0.26	0.53	1.41	0.53
parietal lobe, fetal, donor1	10072-101I9	587.72	38.79	37.82	43.64	53.34	3.88	2.91	3.88	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	2937.42	59.07	73.28	18.69	10.09	5.61	7.85	14.21	1.50	4.86
parotid gland, adult	10199-103F1	370.00	1.23	4.32	0.00	0.62	0.00	0.00	0.00	0.62	0.00
penis, adult	10200-103F2	341.07	8.59	15.04	0.54	2.69	1.07	2.15	2.69	0.54	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	798.97	6.69	16.73	2.42	0.19	2.23	1.30	2.23	0.00	5.39
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	753.39	16.32	20.54	4.95	0.00	3.64	2.77	2.04	1.75	0.15
pineal gland - adult, donor10196	10179-103C8	819.83	43.22	7.74	0.65	0.00	1.29	0.65	3.23	8.39	1.29
pineal gland, adult, donor10252	10160-103A7	2392.54	74.03	26.06	4.15	5.92	1.78	5.33	5.92	7.11	8.88
pineal gland, adult, donor10258	10377-105G8	540.54	21.95	12.54	1.25	0.00	3.14	4.39	3.76	3.76	1.25
pituitary gland - adult, donor10196	10180-103C9	1068.46	27.32	15.18	6.07	1.01	0.00	1.01	1.01	3.04	2.02
pituitary gland, adult, donor10252	10162-103A9	3407.47	54.72	25.54	7.82	1.56	3.13	5.73	5.21	6.78	5.21
pituitary gland, adult, donor10258	10378-105G9	594.17	18.73	22.13	4.26	0.00	7.66	4.26	1.70	2.55	0.85
placenta, adult, pool1	10021-101D3	606.64	2.47	2.26	20.32	1.83	0.22	0.54	1.72	0.54	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	572.08	2.91	7.15	1.32	0.26	0.40	0.79	0.79	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	532.91	2.02	1.71	1.87	1.09	0.16	0.78	0.93	0.78	0.00
pons, adult, pool1	10033-101E6	2127.76	8.78	8.09	33.48	39.59	1.03	1.81	1.46	1.12	0.52
postcentral gyrus, adult, pool1	10032-101E5	349.05	2.27	1.39	17.61	19.09	0.26	0.09	0.26	0.96	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	85.75	0.00	0.00	2.09	0.00	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	258.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	1223.85	15.44	19.96	20.83	1.02	2.91	1.17	0.87	2.18	0.00
prostate cancer cell line:PC-3	10439-106E7	1868.01	24.68	32.31	17.79	1.09	4.36	3.45	3.09	1.27	0.54
prostate, adult, pool1	10022-101D4	897.48	7.71	2.27	2.09	6.62	0.54	0.54	1.18	1.54	2.63
putamen, adult, donor10196	10176-103C5	1821.70	50.05	49.81	33.05	16.05	6.37	6.85	7.79	4.72	1.42
putamen, adult, donor10252	10152-102I8	1256.82	49.02	13.73	39.21	80.39	0.00	9.80	5.88	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	786.82	29.51	31.69	8.74	9.84	2.19	3.28	16.39	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	1155.15	38.66	70.31	18.12	14.74	10.63	6.28	11.84	1.93	1.69
putamen, newborn, donor10223	10365-105F5	6890.89	56.97	99.70	8.25	6.75	9.00	7.50	9.75	3.00	6.75
rectal cancer cell line:TT1TKB	10469-106I1	697.08	2.62	4.65	4.36	0.00	0.87	1.45	0.58	3.20	0.58
rectum, fetal, donor1	10067-101I4	329.67	15.30	5.56	2.78	5.56	0.00	1.39	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	306.97	1.48	2.33	1.27	0.21	0.42	0.21	0.00	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	104.38	2.07	4.56	0.00	0.00	0.41	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	403.56	1.99	2.78	6.36	7.16	0.80	0.30	0.40	1.19	0.00
retinoblastoma cell line:Y79	10475-106I7	1143.39	16.37	18.45	13.25	0.26	1.56	1.56	0.78	2.86	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	868.38	19.67	16.11	6.64	0.12	4.06	2.83	2.34	0.61	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	842.76	1.69	1.97	0.56	0.00	0.28	0.56	0.84	0.84	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	232.66	3.03	3.03	0.00	0.76	0.00	0.76	3.79	0.76	0.00
salivary acinar cells, donor1	11771-123I7	380.69	5.50	10.52	2.59	0.16	0.97	0.32	1.29	0.16	0.16
salivary acinar cells, donor2	11772-123I8	267.11	2.62	11.57	2.48	0.55	1.10	0.55	0.28	0.14	0.00
salivary acinar cells, donor3	11773-123I9	252.24	3.97	6.62	1.99	1.99	0.66	3.97	3.97	0.66	0.00
salivary gland, adult, pool1	10093-102C3	323.15	0.00	1.14	0.57	2.86	0.00	0.00	0.00	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	1158.69	5.65	9.78	2.19	3.04	0.84	0.67	0.34	1.52	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	1135.43	10.11	13.99	2.23	1.29	2.12	1.76	0.71	1.06	0.12
seminal vesicle, adult	10201-103F3	795.19	23.81	8.99	2.12	2.65	0.53	5.82	2.65	1.59	32.80
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1623.47	16.03	42.03	8.99	0.24	3.40	0.97	2.67	4.37	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	307.24	2.52	1.51	2.01	3.02	0.25	0.25	0.50	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	842.97	12.04	19.07	2.01	3.01	3.01	2.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	541.58	4.70	17.60	6.04	1.07	2.55	0.27	0.40	0.27	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	775.46	2.43	5.19	0.77	0.11	0.33	0.33	0.33	0.77	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	1055.81	2.97	2.97	2.71	0.13	0.39	0.39	0.52	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	885.25	34.76	26.95	0.00	2.13	2.13	14.90	15.61	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	507.81	2.76	1.92	1.32	1.92	0.24	0.84	0.60	1.92	0.00
skeletal muscle, fetal, donor1	10066-101I3	136.68	0.00	2.01	1.01	1.01	0.00	1.01	1.01	1.01	0.00
skin, adult, donor1	10074-102A2	312.12	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	394.52	25.25	2.52	1.26	1.89	3.16	1.26	1.89	3.16	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	779.11	8.34	10.67	1.67	0.00	2.00	1.00	1.33	4.34	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1012.75	41.92	58.94	7.56	0.32	4.73	1.89	2.52	1.26	8.83
small cell lung carcinoma cell line:DMS 144	10841-111E4	811.08	2.89	10.22	1.93	0.58	1.93	1.73	0.77	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	1418.50	3.13	4.62	6.92	0.00	0.82	1.15	1.81	1.48	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	558.79	20.27	23.64	2.09	0.80	2.25	1.29	1.29	0.64	6.43
small cell lung carcinoma cell line:WA-hT	10562-108A4	471.57	5.67	9.59	1.53	0.00	2.40	0.87	0.44	2.40	0.44
small intestine, adult, pool1	10024-101D6	564.49	1.79	2.99	2.63	1.19	0.12	0.36	0.24	0.72	0.00
small intestine, fetal, donor1	10064-101I1	402.45	19.41	13.51	1.47	0.74	2.70	1.97	1.23	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	390.32	8.72	21.03	3.59	0.00	3.59	1.03	1.54	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	373.73	10.86	9.05	1.55	4.39	1.81	0.78	1.29	0.78	8.01
somatostatinoma cell line:QGP-1	10781-110G7	345.75	5.63	2.68	4.29	0.00	0.27	1.61	1.07	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	992.41	61.25	43.59	19.27	24.55	3.90	5.74	5.51	2.06	4.82
spinal cord, adult, donor10252	10159-103A6	2631.76	41.79	23.26	44.55	83.19	3.15	6.70	6.31	1.18	27.60
spinal cord, adult, donor10258	10369-105F9	1389.82	38.74	82.32	5.53	22.83	2.77	0.00	4.15	0.69	18.68
spinal cord, fetal, donor1	10056-101H2	442.74	24.39	11.59	8.54	4.88	1.83	3.66	1.83	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	3022.08	46.38	84.50	11.94	34.90	7.81	6.89	10.10	3.67	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	494.51	4.48	5.23	2.99	1.19	0.75	0.75	1.64	1.49	0.00
spleen, adult, pool1	10025-101D7	476.99	1.43	2.09	1.65	0.99	0.55	0.77	1.10	0.11	0.00
spleen, fetal, pool1	10044-101F8	703.73	2.54	0.32	1.91	3.89	0.00	0.16	0.16	0.16	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	688.98	3.52	8.28	0.10	0.00	0.93	0.21	0.31	0.00	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1180.46	10.06	9.68	9.49	0.38	1.14	1.90	2.66	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	483.29	15.03	25.51	4.19	0.35	1.75	0.35	0.70	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	439.02	4.69	9.77	10.95	0.00	1.17	0.78	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	486.03	3.15	4.61	7.20	0.11	0.45	0.23	0.23	1.13	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	873.89	10.59	19.49	2.54	0.42	4.66	0.42	0.42	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	733.18	4.65	4.23	2.96	0.85	2.54	1.27	2.12	4.23	0.42
stomach, fetal, donor1	10062-101H8	290.49	6.41	3.20	1.07	2.14	0.00	0.00	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	685.90	11.96	9.11	0.57	0.57	1.71	0.57	3.42	0.57	5.70
substantia nigra - adult, donor10196	10178-103C7	8086.85	4938.95	5481.69	162.82	379.92	379.92	217.10	759.84	0.00	976.93
substantia nigra, adult, donor10252	10158-103A5	2177.38	62.52	47.77	68.13	100.74	9.76	5.19	4.36	1.25	28.25
substantia nigra, adult, donor10258	10371-105G2	1441.06	50.17	129.83	4.14	21.21	7.76	5.69	8.28	1.03	3.62
substantia nigra, newborn, donor10223	10358-105E7	1819.43	48.75	29.68	7.77	28.26	4.24	2.12	7.77	1.41	8.48
synovial sarcoma cell line:HS-SY-II	10441-106E9	1481.74	26.37	31.18	11.46	1.38	5.73	3.21	2.06	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	325.77	3.05	0.93	17.04	18.06	0.17	0.00	0.17	0.42	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	450.87	42.02	9.97	25.64	14.25	1.42	1.42	0.71	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	360.42	14.07	16.26	20.66	25.05	1.76	1.32	0.44	0.88	1.32
tenocyte, donor1	11763-123H8	293.94	3.84	7.33	2.09	2.79	1.05	0.35	0.70	0.35	0.00
tenocyte, donor2	11765-123I1	225.09	1.53	6.10	1.53	4.58	0.00	0.00	0.38	0.00	0.00
tenocyte, donor3	11768-123I4	338.05	3.34	13.34	1.85	2.22	1.11	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1288.98	24.30	20.57	10.37	1.53	3.57	2.55	2.89	1.02	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	729.74	12.02	10.94	3.55	0.15	3.08	2.00	0.92	1.08	0.31
teratocarcinoma cell line:PA-1	10807-111A6	629.36	11.31	11.62	6.04	0.77	1.70	1.24	0.93	0.62	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	789.99	14.73	16.12	5.71	0.13	2.92	1.40	2.03	2.41	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4759.68	45.76	66.94	10.97	0.76	9.45	3.78	9.83	6.05	6.81
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	3548.24	25.96	30.76	3.49	0.55	4.47	2.84	3.60	1.85	4.69
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2041.83	46.58	118.88	3.58	0.00	9.45	5.86	3.91	2.61	0.98
testis, adult, pool1	10026-101D8	1062.34	3.76	5.05	4.19	7.73	0.75	1.18	0.75	4.19	0.32
testis, adult, pool2	10096-102C6	576.94	59.54	40.15	7.67	7.22	3.16	1.35	4.06	6.77	1.35
thalamus - adult, donor10196	10168-103B6	1661.50	85.01	43.06	28.70	46.37	7.73	5.52	6.62	4.42	9.94
thalamus, adult, donor10252	10154-103A1	2274.85	82.67	48.14	65.95	120.34	8.91	4.69	5.00	2.03	31.57
thalamus, adult, donor10258, tech_rep1	10370-105G1	788.28	44.65	18.48	7.70	46.19	13.86	3.08	23.09	0.00	23.09
thalamus, adult, donor10258, tech_rep2	10370-105G1	769.60	32.28	24.87	10.05	20.75	4.28	3.95	5.60	0.82	5.93
thalamus, newborn, donor10223	10366-105F6	2832.30	49.48	54.08	8.05	2.88	4.03	6.33	13.81	5.75	2.30
throat, adult	10209-103G2	612.69	6.24	5.74	0.25	2.50	1.50	1.50	0.75	1.75	2.25
throat, fetal, donor1	10061-101H7	368.08	11.88	7.92	2.74	2.44	2.44	1.52	0.30	1.22	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	827.12	13.51	14.90	5.56	0.00	0.79	0.20	1.19	0.79	0.00
thymus, adult, pool1	10027-101D9	798.90	1.99	3.58	2.58	0.89	0.10	0.89	0.80	0.40	0.10
thymus, fetal, pool1	10043-101F7	2462.02	11.95	7.79	4.16	1.25	0.42	1.25	2.08	0.52	6.23
thyroid carcinoma cell line:KHM-5M	10776-110G2	791.38	8.24	10.90	2.13	0.00	1.99	1.33	0.66	0.40	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	439.89	6.71	8.80	0.84	0.56	2.10	0.70	1.12	1.68	0.42
thyroid, adult, pool1	10028-101E1	1444.86	7.28	5.79	3.45	1.31	0.37	1.21	1.03	2.43	1.03
thyroid, fetal, donor1	10060-101H6	397.34	21.88	11.34	1.85	0.79	1.85	0.79	2.64	0.53	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	169.38	27.72	6.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	419.10	6.51	10.47	1.16	1.16	1.40	1.40	1.86	1.16	2.09
tongue, fetal, donor1	10059-101H5	453.99	16.95	19.31	0.79	2.36	3.55	0.39	0.39	1.58	0.39
tonsil, adult, pool1	10047-101G2	281.89	2.30	0.20	2.10	0.50	0.10	0.00	0.10	0.30	1.30
trachea, adult, pool1	10029-101E2	1260.60	3.60	3.60	1.72	1.31	0.41	0.65	0.57	1.47	3.27
trachea, fetal, donor1	10058-101H4	742.84	33.47	15.00	1.54	1.92	1.54	3.46	2.31	1.54	26.93
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	437.53	8.50	10.27	0.71	0.00	2.48	2.83	1.77	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	1344.47	2.03	3.04	8.41	0.30	0.61	0.61	0.41	0.51	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	991.05	10.34	13.01	27.42	2.19	2.19	1.72	0.78	0.63	0.31
tridermal teratoma cell line:HGRT	10694-109G1	336.75	3.81	3.81	3.81	0.00	0.00	9.51	17.12	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	412.59	4.40	5.76	0.68	0.00	0.93	0.51	0.76	0.51	0.42
umbilical cord, fetal, donor1	10057-101H3	277.50	8.35	8.35	0.00	2.09	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	492.60	2.56	1.02	4.27	10.41	0.17	0.17	0.17	0.34	3.24
uterus, fetal, donor1	10055-101H1	356.81	17.41	7.68	1.02	2.56	1.02	0.51	0.51	1.02	5.63
vagina, adult	10204-103F6	6330.16	49.76	45.23	6.46	25.20	2.58	5.17	13.57	7.75	13.57
vein, adult	10191-103E2	234.76	2.41	4.60	1.53	2.19	0.66	0.88	0.44	0.44	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	249.68	3.47	8.81	0.53	0.00	0.53	0.53	0.00	0.00	0.27